WO2009106399A1 - Hair treatment means with cranberry extract - Google Patents

Hair treatment means with cranberry extract Download PDF

Info

Publication number
WO2009106399A1
WO2009106399A1 PCT/EP2009/050923 EP2009050923W WO2009106399A1 WO 2009106399 A1 WO2009106399 A1 WO 2009106399A1 EP 2009050923 W EP2009050923 W EP 2009050923W WO 2009106399 A1 WO2009106399 A1 WO 2009106399A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
hair
agent
preferred
compositions according
Prior art date
Application number
PCT/EP2009/050923
Other languages
German (de)
French (fr)
Inventor
Marcus Krueger
Dieter Goddinger
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2009106399A1 publication Critical patent/WO2009106399A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/04Preparations for permanent waving or straightening the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/08Preparations for bleaching the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair

Definitions

  • the present invention relates to the cosmetic use of a cranberry extract for
  • a care complex should be provided, which can also be used in conjunction with oxidizing agent.
  • Fibers especially human hair, with the application of an effective fiber protection against environmental influences, such as UV protection, are connected.
  • Cranberry in the following cranberry extract, is dissolved.
  • Mossberry also called cranberry (Vaccinium macrocarpon).
  • a first subject of the present invention are therefore cosmetic agents for the treatment of keratinic fibers, in particular human hair, contained in a cosmetic
  • Carrier an extract from the fruits of Vaccinium macrocarpon (cranberry extract).
  • the cosmetic agents are used to treat keratinous fibers, in particular human hair.
  • Preferred agents according to the invention are therefore shampoos, conditioners or hair tonics.
  • the avivage can be significantly improved by using the cranberry extract. This manifests itself in an improvement in the combability, feel or shape of keratinous fibers, especially human hair.
  • combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber.
  • the measuring parameters can be sensory assessed by the skilled person or quantified by measuring devices.
  • the grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
  • Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
  • keratinous fibers By maintaining the natural growth of keratinous fibers, it is understood that the effects on natural hair growth are compensated by hair cosmetic treatments as outlined above, in particular by oxidative hair treatments, and no or at least slight effects on the natural growth of the keratinic fibers in terms of thickness growth, the growth in length and / or in relation to the hair fullness are present.
  • the growth in thickness, the growth in length or the hair fullness can be determined both subjectively and objectively or in different test models.
  • an oxidative hair treatment the action of an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.
  • the cranberry extract is preferably used immediately before, during or after the oxidative hair treatment in the form of an agent containing a cranberry extract in a cosmetic carrier.
  • an application directly followed by the oxidative hair treatment wherein the cranberry extract-containing agent has previously been rinsed from the hair or preferably left on the hair and the hair is preferably still wet ,
  • an application following the oxidative hair treatment is understood as meaning after the oxidative hair treatment, wherein the agent containing a cranberry extract after rinsing the hair dye or the bleaching agent or the waving agent on the preferably still wet, towel-dried Hair is applied, or applied to dry or wet hair only after several hours or days.
  • the agent according to the invention can be rinsed out again after a contact time of a few seconds up to 45 minutes or remain completely on the hair.
  • the effect of the agent according to the invention unfolds even during the oxidative hair treatment and surprisingly persists even after intensive washing out of the composition according to the invention.
  • the cranberry extract is preferably used in a cosmetic carrier.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • cosmetic carriers are aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alkyl alcohol, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, Iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand.
  • the compositions of the invention may additionally contain other organic solvents, such as methoxybutanol,
  • a preferred suitable cranberry extract under the trade name Fruit Cranberry Liquid B ® from Crodarom distributed (INCI name (EU): glycerol, Water, Vaccinium Macrocarpon (Cranberry) Fruit Extract, 5.0-10.0 wt .-%. Active substance in Glycerin / Water).
  • the cosmetic compositions according to the invention contain the extracted substances from the fruits of the cranberry preferably in an amount of 0.0001 to 3.0 wt .-%, particularly preferably from 0.01 to 1, 0 wt .-%, most preferably from 0 , 05 to 0.5 wt .-%, each based on the weight of the ready-to-use agent.
  • the agents according to the invention also contain at least one further active ingredient.
  • this further active ingredient is selected from the group formed from L-carnitine tartrate, coenzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and their derivatives or physiologically acceptable salts.
  • betaines are betaines.
  • the betaines according to the invention are to be understood as meaning those which correspond to the formula (A-I).
  • betaines of the formula (AI) are: carnitine, carnitine tartrate, carnitine magnesium citrate, acetylcarnitine, taurine, taurine lysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine, 1,1-dimethyl-proline, hercynine (N ', N ', N'-trimethyl-L-histidinium betaine), choline, choline chloride, choline bitartrate,
  • compositions according to the invention may contain both a compound according to formula (AI) and several, in particular two, compounds of formula (AI).
  • the active ingredient used is L-carnitine tartrate.
  • the cosmetic composition contains, in addition to the cranberry extract, taurine and / or at least one of its derivatives.
  • taurine is meant 2-aminoethanesulfonic acid.
  • Taurine derivatives are N-monomethyltaurine and N, N-dimethyltaurine. Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
  • compositions of the invention contain biochinones which act as coenzymes.
  • suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
  • the preferred ubiquinones according to the invention have the following formula:
  • the cosmetic agent contains a combination of coenzyme Q-10 (ubiquinone-50) and / or at least one of its derivatives and cranberry extract.
  • the cosmetic composition contains a combination of ectoine ((S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid) and / or at least one of its derivatives and cranberry extract ,
  • the cosmetic composition contains a combination of pantolactone ((R) -dihydro-3-hydroxy-4,4-dimethyl-2 (3H-furanone) and cranberry extract
  • the cosmetic composition comprises a combination of pantothenic acid and / or at least one of its derivatives and cranberry extract Pantothenic acid is preferred as a derivative in the form of the more stable calcium salts and sodium salts (Ca-pantothenate
  • Other suitable pantothenic acid derivatives in the context of the present invention are panthenol and panthethein Particularly preferred according to the invention are agents which, based on their weight, have 0.00001 to
  • % preferably 0.0001 to 5.0 wt .-%, of the active ingredients from the group formed by Car nitintartrate, co-enzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and their derivatives.
  • compositions according to the invention may also contain carnitine tartrate, coenzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and / or derivatives thereof in the form of natural product extracts obtained from natural products containing the corresponding active ingredients or their derivatives. It may furthermore be particularly preferred if the agent according to the invention additionally contains at least one conditioning agent.
  • Preferred conditioning agents are selected from the group consisting of cationic surfactants, cationic polymers and silicones. Very particularly cationic polymers are used as further ingredients in the compositions according to the invention.
  • Preferred cationic polymers are commercially available and, for example, quaternized cellulose derivatives, cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of
  • Acrylic acid and methacrylic acid are Acrylic acid and methacrylic acid.
  • Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate such as vinylpyrrolidone quaternized with diethyl sulfate
  • Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers quaternized polyvinyl alcohol and those under the names Polyquaternium 2,
  • Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain
  • the cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • a last group of substances which can additionally be used as conditioning agents in the compositions according to the invention are silicone oils (in the following also silicones).
  • the conditioning agent is a conditioning silicone having a viscosity of from 20,000 to 120,000 mPa s, most preferably from 40,000 to 80,000 mPa s.
  • the conditioning silicone is particularly preferably selected from dimethicones, amodimethicones or dimethiconols.
  • the agent according to the invention may be used in the context of a color change of the hair.
  • the oxidative color change is preferred because the care effect of the compositions of the invention is excellent even in the presence of an oxidizing agent.
  • the cosmetic agents additionally preferably contain at least one color-modifying component.
  • the authenticity of the color obtained against environmental influences is improved.
  • the color-changing component is again preferably selected
  • the cosmetic agent therefore additionally contains at least one oxidation dye precursor of the developer component type.
  • the actual oxidative colorant is prepared by separate storage of the dye precursors and the oxidizing agent immediately before use by mixing.
  • the cosmetic agent is therefore mixed before application from a composition comprising at least one color-modifying component in a cosmetic carrier and a further composition containing at least one oxidizing agent in a cosmetic carrier.
  • the ready-to-use composition is conveniently prepared immediately prior to use by mixing a composition containing the oxidizing agent with the composition containing the color-changing components.
  • the resulting ready-to-use hair preparation should preferably have a pH in the range from 6 to 12, in particular from pH 7.5 to 10.
  • at least one bleaching booster is preferably used in the cosmetic compositions according to the invention.
  • Bleach boosters are preferably used in bleaching agents for increasing the bleaching action of the oxidizing agent, in particular the hydrogen peroxide.
  • the bleach boosters are present in the cosmetic agents according to the invention preferably in amounts of from 5 to 30% by weight, in particular in amounts of from 8 to 20% by weight.
  • the cosmetic agents of the invention when acting as a bleaching agent, contain as preferred alkalizing agent at least one compound selected from ammonium, alkali metal and alkaline earth metal hydroxides, carbonates, bicarbonates, hydroxycarboxylates, metasilicates and carbamides, as well as alkali phosphates.
  • the cosmetic agents used in the process according to the invention may furthermore contain all active ingredients, additives and auxiliaries known for such preparations: Washing with a shampoo is unnecessary if a carrier which is highly surfactant-containing was used.
  • the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle.
  • the choice of surfactants depends on the nature of the agent.
  • at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen.
  • These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • the ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5.
  • the ratio is particularly preferably 5: 1 to 1: 2.
  • cationic surfactants are preferably used as surface-active substances or nonionic surfactants selected. Again, a selection of the so-called mild surface-active substances is particularly preferred.
  • Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettkladensate.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic and Alkylaminoessigklaroy each having about 8 to 24 carbon atoms in the alkyl group.
  • ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • the alkylene oxide adducts to saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid and the sugar surfactants have proven. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
  • Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.
  • Anionic surfactants are used in particular when the compositions according to the invention are to be used as shower baths.
  • the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total amount used in accordance with the invention Medium, used.
  • Emulsifiers which can be used according to the invention are, for example
  • Alkylphenols having 8 to 15 C atoms in the alkyl group having 8 to 15 C atoms in the alkyl group
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which bind to C-atom 3 of the
  • Steroid scaffold carry a hydroxyl group and both from animal tissue
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol, Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • compositions of the invention preferably contain the emulsifiers in quantities of 0.1 to 25 bew.- 0 / o in particular 0.5 to 15 wt .-%, based on the total agent.
  • amphoteric polymers as well as the cationic polymers according to the invention are very particularly preferred polymers.
  • amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO 3 H groups and are capable of forming internal salts, as well as zwitterionic polymers which in the molecule have quaternary ammonium groups and -COO or -SO 3 " groups, and those polymers comprising -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt , Particularly preferred is the homopolymer of 2-acrylamido-2-methylpropanesulfonic acid, which is commercially available, for example, under the name Rheothik®11-80.
  • the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the agents according to the invention may contain nonionogenic polymers.
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.
  • Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).
  • protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates.
  • the latter include, for example, polyalanine, polyasparagine, polyserine, etc.
  • compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride.
  • ⁇ -amino acids and their derivatives such as ⁇ -alanine, anthranilic acid or hippuric acid can also be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are sold, for example, under the trademarks Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (German Gelatin Factories Stoess & Co), Lexein® (Inolex) and Kerasol® (Croda).
  • vegetable protein hydrolysates such as moringa, soybean, almond, pea, potato and wheat protein hydrolysates are preferred according to the invention.
  • Such products are available, for example, under the trademarks Puricare® LS 9658 (Laboratories Serobiiquess), Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy® (Croda), Hydrolupin® (Croda), Hydrosesame® (Croda ), Hydrotritium® (Croda) and Crotein® (Croda).
  • Further preferred protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl extracts.
  • the protein hydrolysates (P) are present in the compositions at levels of from 0.001% to 20% by weight, preferably from 0.05% to 15% by weight, and most preferably in amounts of 0, 05 wt .-% up to 5 wt .-% included.
  • compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • Preferred are the Sodium, potassium, calcium, magnesium or ammonium salts, in which the ammonium ion in addition to hydrogen carries one to three C1 to C4 alkyl groups.
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt .-%, based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt .-%.
  • vitamins are vitamins, provitamins or vitamin precursors.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • compositions according to the invention may additionally contain antimicrobial compounds.
  • Suitable antimicrobial compounds are, for. B. cationic surfactants such.
  • Good are also the antimicrobial biguanide compounds such.
  • the polyhexamethylene biguanide (Vantocil® IB, ICI) or the 1, 1 ' hexamethylene bis (4-chlorophenyl) biguanide (“chlorhexidine”) in the form of a water-soluble, compatible salt, e.g. In the form of the acetate or gluconate.
  • the antimicrobial 5-amino-hexahydropyrimidines, z for example, the 1, 3-bis (2-ethylhexyl) -5-methyl-5-amino-hexahydropyrimidine ("hexetidine”).
  • suitable antimicrobial agents are the non-cationic, phenolic, antimicrobial substances, in particular the halogenated phenols and diphenyl ethers.
  • Particularly suitable antimicrobial compounds of this type are z. B. the 6,6 ' - methylene-bis- (2-bromo-4-chlorophenol) ("bromochlorophene”) and the 2,4,4 ' trichloro-2 ' hydroxy-diphenyl ether ("Triclosan").
  • agents according to the invention may contain purine and / or derivative (s) of the purine. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
  • Cosmetic agents preferred according to the invention are characterized in that they contain purine and / or purine derivative (s) of the formula (I) or (II)
  • radicals R 1 , R 2 and R 3 of the formula (I) are selected independently of one another from -H, - OH, -NH 2 , -SH and the radicals R4, R5 and R6 of the formula (II) independently of one another are selected from -H, -CH 3 and -CH 2 -CH 3 are substituted, where the following compounds according to formula (I):
  • Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the agent) can be used.
  • compositions according to the invention contain penetration aids and / or swelling agents (M).
  • M penetration aids and / or swelling agents
  • M include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1 , 6-hexanediol, 1, 5-pentanediol, 1, 4-
  • a particularly preferred group of swelling agents may be hydantoins. Regardless of whether hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
  • the cosmetic compositions of the invention may contain pharmacologically active substances.
  • pharmacologically active substances are corticosteroids, ⁇ -blockers, estrogens, phytoestrogens, cyproterone acetate, vasodilating substances such as diazoxide, nifedipine and minoxidil, acetylsalicylic acid or salicylic acid. These substances are contained in amounts of from 0.01 to 10% by weight, based in each case on the entire composition.
  • the compositions of the invention contain a bittering agent to prevent swallowing or accidental ingestion.
  • Bitter substances which are soluble in water at 20 ° C. to at least 5 g / l are preferred according to the invention.
  • Quaternary ammonium compounds which contain an aromatic group both in the cation and in the anion are outstandingly suitable as bitter substances.
  • One such compound is benzyldiethyl ((2,6-xylylcarbamoyl) methyl) ammonium benzoate commercially available, for example, under the trade names Bitrex® and Indigo-stin®. This compound is also known by the name Denatonium Benzoate.
  • the bittering agent is contained in the compositions of the invention in amounts of 0.0005 to 0.1 wt .-%, based on the composition. Particular preference is given to amounts of from 0.001 to 0.05% by weight.
  • the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • the pH of the compositions according to the invention is preferably between 2 and 12.
  • the adjustment of the pH of the cosmetic compositions according to the invention is carried out using the carboxylic acids or mineral acids such as phosphoric acid, sulfuric acid, etc ..
  • the alkalizing agents are inorganic compounds, preferably hydroxides or ammonia and organic bases, preferably amines and including in particular alkanolamines, can be used.
  • Preferred agents according to the invention additionally comprise, in addition to a cranberry extract, in one cosmetic carrier one of the following active ingredient combinations (xiii) to (xx): (xiii) pantolactone and at least one cationic surfactant, (xiv) pantolactone and at least one cationic polymer, (xv) pantolactone and at least one silicone, (xvi) pantolactone and at least one UV absorber, (xvii) ectoine and at least one cationic surfactant, (xviii) ectoine and at least one cationic polymer,
  • a second subject of the invention is therefore a process for the treatment of keratinic fibers, in which a cosmetic composition containing in a cosmetic carrier a
  • Cranberry extract applied and optionally rinsed again after an exposure time.
  • the exposure time of the cranberry extract is preferably a few seconds to 100 minutes, more preferably a few seconds to 45 minutes and most preferably 1 to 30
  • Carrier at least one oxidizing agent is applied to the hair and after a
  • Cranberry extract applied and optionally rinsed again after an exposure time.
  • cranberry extract as part of a cosmetic
  • a cosmetic carrier By means of containing in a cosmetic carrier additionally at least one oxidizing agent and at least one oxidation dye precursor applied in one step.
  • the oxidative hair dyes of this embodiment are preferably two-component agents.
  • the first component contains in a cosmetic carrier a cranberry extract and at least one oxidation dye precursor.
  • the second component contains at least one oxidizing agent in a cosmetic carrier.
  • Packing unit (kit) provided. Shortly before use, both components are mixed together.
  • the oxidative hair bleaches of this embodiment are preferably two- or three-component agents.
  • the first component contains in a cosmetic carrier a cranberry extract and optionally at least one bleach booster.
  • the bleach booster may also be formulated separately from the cranberry extract, for example in powder form, as an anhydrous paste or an anhydrous oil. Thereby, a three-component agent is obtained.
  • the last component contains at least one oxidizing agent in a cosmetic carrier. All components are preferably packaged separately in each case in a compartment and provided together in a packaging unit (kit). Just before use, all components are mixed together.
  • the multi-component means described above for carrying out the method according to the invention can be provided in a packaging unit.
  • the packaging unit may comprise at least either a container containing the agent of the second subject of the invention or may comprise at least two containers, a first container containing an oxidative cosmetic agent containing at least one oxidizing agent in a cosmetic carrier, a second container containing a cosmetic agent containing in a cosmetic carrier a cranberry extract, and optionally a third container containing at least one bleach booster embedded in a cosmetic carrier. All Kontainer can also be chambers of a multi-chamber container. For the second subject of the invention applies mutatis mutandis what has been said for the first subject of the invention.
  • a third aspect of the present invention is therefore the use, in particular of a cosmetic composition containing a cranberry extract for the treatment of keratin-containing fibers, in particular human hair.
  • the cosmetic agent containing a cranberry extract is used for the repair and / or restructuring of damaged hair.
  • the agent according to the invention is particularly preferably used for the repair and / or restructuring of hair damage caused by oxidation or UV light.
  • the agent according to the invention can be used in a further preferred embodiment for protecting keratin-containing fibers from moisture loss and / or from external influences, such as oxidative treatment or UV radiation.
  • a further preferred embodiment of the present invention comprises the use of the agents according to the invention for improving the shine of keratin-containing fibers, in particular human hair, for improving the combability of keratin-containing fibers, in particular human hair, for improving the feel of keratin-containing fibers, in particular human hair, and for improving the Shaping keratin fibers, especially human hair.
  • the agent according to the invention is used on dyed or tinted keratinic fibers, in particular human hair, for
  • Stenol® 16/18 C 16 . 18 fatty alcohol (INCI name: Cetearyl Alcohol;

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

An extract of the fruits of cranberries (vaccinium macrocarpon) is excellently suited for the treatment of keratin fibers, in particular human hair, for improving the moisture in the fiber, repairing and restructuring the fibers and for protecting the fibers from oxidants and UV radiation, and for improving the color retention and color intensity when the fibers are colored hairs.

Description

"Haarbehandlungsmittel mit Cranberry-Extrakt" "Hair treatment product with cranberry extract"
Die vorliegende Erfindung betrifft die kosmetische Verwendung eines Cranberry-Extrakt zurThe present invention relates to the cosmetic use of a cranberry extract for
Verbesserung der Avivage, zur Verbesserung des Glanzes sowie zum Schutz derImprovement of the finish, to improve the shine and to protect the
Destrukturierung keratinhaltiger Fasern, insbesondere menschlicher Haare, durch UV-Strahlung und zur Aufrechterhaltung des Haarwachstumes.Destructuring keratin fibers, especially human hair, by UV radiation and to maintain the hair growth.
Es besteht das Bedürfnis, Haarpflegeprodukte weiter zu verbessern und ihnen weitere vorteilhafteThere is a need to further improve hair care products and give them more benefits
Eigenschaften zu verleihen. Dabei sollte insbesondere ein Pflegekomplex bereitgestellt werden, der auch in Verbindung mit Oxidationsmittel eingesetzt werden kann.To give properties. In particular, a care complex should be provided, which can also be used in conjunction with oxidizing agent.
Es ist daher eine Aufgabe der vorliegenden Erfindung, die zuvor beschriebenen Nebenwirkungen oxidativer Haarbehandlungen im Rahmen eines 2-in-1-Produktes bereits vorzugsweise während der oxidativen Haarbehandlung aber auch nach der oxidativen Haarbehandlung zu verringern, ohne den Wirkungsgrad des oxidativen Kosmetikums, insbesondere bezüglich Farbintensität,It is therefore an object of the present invention to reduce the previously described side effects of oxidative hair treatments in the context of a 2-in-1 product already preferably during the oxidative hair treatment but also after the oxidative hair treatment, without the efficiency of the oxidative cosmetic, in particular with respect to color intensity .
Farbechtheit, Aufhellleistung bzw. Wellwirkung, zu verschlechtern. Darüber hinaus soll in Form eines 2-in-1 -Produktes in einem Anwendungsschritt die oxidative Behandlung keratinhaltigerColor fastness, brightening power or corrugated effect, to deteriorate. In addition, in the form of a 2-in-1 product in an application step, the oxidative treatment keratinhaltiger
Fasern, insbesondere menschlicher Haare, mit der Applikation eines wirksamen Faserschutzes vor Umwelteinflüssen, beispielsweise eines UV-Schutzes, verbunden werden.Fibers, especially human hair, with the application of an effective fiber protection against environmental influences, such as UV protection, are connected.
Es wurde nun überraschenderweise gefunden, dass die Aufgabe in hervorragendem Maße durch die Verwendung eines kosmetischen Mittels, enthaltend einen Extrakt aus den Früchten derIt has now surprisingly been found that the object is achieved to a great extent by the use of a cosmetic agent containing an extract of the fruits of the
Cranberry (im folgenden Cranberry-Extrakt), gelöst wird.Cranberry (in the following cranberry extract), is dissolved.
Unter der Bezeichnung „Cranberry" wird im Rahmen dieser Schrift die Frucht der GroßfrüchtigenUnder the name "Cranberry" is in this document the fruit of the large-fruited
Mossbeere, auch Kranbeere (Vaccinium macrocarpon) bezeichnet.Mossberry, also called cranberry (Vaccinium macrocarpon).
Ein erster Gegenstand der vorliegenden Erfindung sind daher kosmetische Mittel zur Behandlung keratinischer Fasern, insbesondere menschlicher Haare, enthaltend in einem kosmetischenA first subject of the present invention are therefore cosmetic agents for the treatment of keratinic fibers, in particular human hair, contained in a cosmetic
Träger einen Extrakt aus den Früchten von Vaccinium Macrocarpon (Cranberry-Extrakt).Carrier an extract from the fruits of Vaccinium macrocarpon (cranberry extract).
In einer bevorzugten Ausführungsform der vorliegenden Erfindung dienen die kosmetischen Mittel zur Behandlung keratinischer Fasern, insbesondere menschlicher Haare. Bevorzugte erfindungsgemäße Mittel sind daher Shampoos, Konditioniermittel oder Haar-Tonics. Die Avivage kann durch die Anwendung des Cranberry-Extrakts erheblich verbessert werden. Dies manifestiert sich in einer Verbesserung der Kämmbarkeit, des Griffs oder der Formgebung keratinhaltiger Fasern, insbesondere menschlicher Haare. Unter Kämmbarkeit versteht sich erfindungsgemäß sowohl die Kämmbarkeit der nassen Faser, als auch die Kämmbarkeit der trockenen Faser. Als Maß für die Kämmbarkeit dient die aufgewendete Kämmarbeit oder die aufgewendete Kraft während des Kämmvorganges eines Faserkollektivs. Die Meßparameter können durch den Fachmann sensorisch beurteilt oder durch Messeinrichtungen quantifiziert werden.In a preferred embodiment of the present invention, the cosmetic agents are used to treat keratinous fibers, in particular human hair. Preferred agents according to the invention are therefore shampoos, conditioners or hair tonics. The avivage can be significantly improved by using the cranberry extract. This manifests itself in an improvement in the combability, feel or shape of keratinous fibers, especially human hair. By combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber. As a measure of the combing used the combing work or the force used during the combing process of a fiber collective. The measuring parameters can be sensory assessed by the skilled person or quantified by measuring devices.
Als Griff definiert sich die Taktilität eines Faserkollektivs, wobei der Fachmann sensorisch die Parameter Fülle und Geschmeidigkeit des Kollektivs fühlt und bewertet.The grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
Unter Formgebung wird die Fähigkeit verstanden, einem Kollektiv zuvor behandelter keratinhaltiger Fasern, insbesondere menschlicher Haare, eine Formänderung zu verleihen. In der Haarkosmetik wird auch von Frisierbarkeit gesprochen.Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
Unter der Aufrechterhaltung des natürlichen Wachstum keratinischer Fasern wird verstanden, dass die Einflüsse auf das natürliche Haarwachstum durch haarkosmetische Behandlungen wie zuvor dargestellt, insbesondere durch oxidative Haarbehandlungen ausgeglichen werden und keine oder allenfalls geringe Auswirkungen auf das natürliche Wachstum der keratinischen Fasern in Bezug auf das Dickenwachstum, das Längenwachstum und/oder in Bezug auf die Haarfülle vorhanden sind. Das Dickenwachstum, das Längenwachstum oder die Haarfülle kann dabei sowohl subjektiv als auch objektiv oder in verschiedenen Testmodellen bestimmt werden. Unter einer oxidativen Haarbehandlung wird erfindungsgemäß die Einwirkung eines oxidativen kosmetischen Mittels, enthaltend in einem kosmetischen Träger mindestens ein Oxidationsmittel, auf Haar definiert.By maintaining the natural growth of keratinous fibers, it is understood that the effects on natural hair growth are compensated by hair cosmetic treatments as outlined above, in particular by oxidative hair treatments, and no or at least slight effects on the natural growth of the keratinic fibers in terms of thickness growth, the growth in length and / or in relation to the hair fullness are present. The growth in thickness, the growth in length or the hair fullness can be determined both subjectively and objectively or in different test models. In the context of an oxidative hair treatment, the action of an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.
Das Cranberry-Extrakt wird bevorzugt unmittelbar vor, während oder nach der oxidativen Haarbehandlung in Form eines Mittels, enthaltend in einem kosmetischen Träger ein Cranberry- Extrakt, verwendet. Als unmittelbar vor der oxidativen Haarbehandlung versteht sich im Sinne der Erfindung eine Anwendung, an die sich direkt die oxidative Haarbehandlung anschließt, wobei das einen Cranberry-Extrakt enthaltende Mittel zuvor vom Haar gespült oder bevorzugt auf dem Haar belassen wurde und das Haar bevorzugt noch naß ist.The cranberry extract is preferably used immediately before, during or after the oxidative hair treatment in the form of an agent containing a cranberry extract in a cosmetic carrier. As immediately before the oxidative hair treatment is understood in the context of the invention, an application directly followed by the oxidative hair treatment, wherein the cranberry extract-containing agent has previously been rinsed from the hair or preferably left on the hair and the hair is preferably still wet ,
Als nach der oxidativen Haarbehandlung versteht sich im Sinne der Erfindung eine Anwendung, welche sich entweder direkt an die oxidative Haarbehandlung anschließt, wobei das einen Cranberry-Extrakt enthaltende Mittel nach dem Abspülen des Haarfärbemittels oder des Bleichmittels oder des Wellmittels auf das bevorzugt noch nasse, handtuchtrockene Haar aufgetragen wird, oder erst nach mehreren Stunden oder Tagen auf das trockene oder nasse Haar aufgetragen wird. In beiden Fällen kann das erfindungsgemäße Mittel hierbei nach einer Einwirkzeit von wenigen Sekunden bis hin zu 45 Minuten wieder ausgespült werden oder vollständig auf dem Haar verbleiben.For the purposes of the invention, an application following the oxidative hair treatment is understood as meaning after the oxidative hair treatment, wherein the agent containing a cranberry extract after rinsing the hair dye or the bleaching agent or the waving agent on the preferably still wet, towel-dried Hair is applied, or applied to dry or wet hair only after several hours or days. In both cases, the agent according to the invention can be rinsed out again after a contact time of a few seconds up to 45 minutes or remain completely on the hair.
Die Wirkung des erfindungsgemäßen Mittels entfaltet sich sogar während der oxidativen Haarbehandlung und hält überraschenderweise auch nach intensivem Auswaschen des erfindungsgemäßen Mittels an.The effect of the agent according to the invention unfolds even during the oxidative hair treatment and surprisingly persists even after intensive washing out of the composition according to the invention.
Der Cranberry-Extrakt wird bevorzugt in einem kosmetischen Träger verwendet. Die kosmetischen Träger können insbesondere wässrig oder wässrig-alkoholisch sein. Ein wässriger kosmetischer Träger enthält mindestens 50 Gew.-% Wasser. Unter wässrig-alkoholischen kosmetischen Trägern sind im Sinne der vorliegenden Erfindung wässrige Lösungen enthaltend 3 bis 70 Gew.-% eines C1-C6-AIkOhOIs, insbesondere Methanol, Ethanol bzw. Propanol, Isopropanol, Butanol, Isobutanol, tert.-Butanol, n-Pentanol, iso-Pentanole, n-Hexanol, iso- Hexanole, Glykol, Glycerin, 1 ,2-Pentandiol, 1 ,5-Pentandiol, 1 ,2-Hexandiol oder 1 ,6-Hexandiol zu verstehen. Die erfindungsgemäßen Mittel können zusätzlich weitere organische Lösemittel, wie beispielsweise Methoxybutanol, Benzylalkohol, Ethyldiglykol oder 1 ,2-Propylenglykol, enthalten. Bevorzugt sind dabei alle wasserlöslichen organischen Lösemittel.The cranberry extract is preferably used in a cosmetic carrier. The cosmetic carriers may in particular be aqueous or aqueous-alcoholic. An aqueous cosmetic carrier contains at least 50% by weight of water. Under watery-alcoholic For the purposes of the present invention, cosmetic carriers are aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alkyl alcohol, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, Iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand. The compositions of the invention may additionally contain other organic solvents, such as methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2-propylene glycol. Preference is given to all water-soluble organic solvents.
Ein bevorzugt einsetzbarer Cranberry-Extrakt wird unter dem Handelsnamen Fruitliquid Cranberry B® der Fa. Crodarom vertrieben (INCI-Bezeichnung (EU): Glycerin, Water, Vaccinium Macrocarpon (Cranberry) Fruit Extract; 5,0-10,0 Gew.-% Aktivsubstanz in Glycerin/Water). Die erfindungsgemäßen kosmetischen Mittel enthalten die extrahierten Stoffe aus den Früchten der Cranberry bevorzugt in einer Menge von 0,0001 bis 3,0 Gew.-%, besonders bevorzugt von 0,01 bis 1 ,0 Gew.-%, ganz besonders bevorzugt von 0,05 bis 0,5 Gew.-%, jeweils bezogen auf das Gewicht des anwendungsbereiten Mittels.A preferred suitable cranberry extract under the trade name Fruit Cranberry Liquid B ® from Crodarom distributed (INCI name (EU): glycerol, Water, Vaccinium Macrocarpon (Cranberry) Fruit Extract, 5.0-10.0 wt .-%. Active substance in Glycerin / Water). The cosmetic compositions according to the invention contain the extracted substances from the fruits of the cranberry preferably in an amount of 0.0001 to 3.0 wt .-%, particularly preferably from 0.01 to 1, 0 wt .-%, most preferably from 0 , 05 to 0.5 wt .-%, each based on the weight of the ready-to-use agent.
In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Mittel weiterhin mindestens einen weiteren Wirkstoff.In a preferred embodiment, the agents according to the invention also contain at least one further active ingredient.
Insbesondere wird dieser weitere Wirkstoff ausgewählt der Gruppe, die gebildet wird aus L- Carnitin Tartrat, Coenzym Q-10, Ectoin, Pantolacton, Pantothensäure, Taurin und deren Derivaten oder physiologisch vertretbaren Salzen.In particular, this further active ingredient is selected from the group formed from L-carnitine tartrate, coenzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and their derivatives or physiologically acceptable salts.
Eine weitere besonders bevorzugte Gruppe von Inhaltsstoffen in den erfindungsgemäßen kosmetischen Zusammensetzungen sind Betaine. Insbesondere sind unter den erfindungsgemäßen Betainen solche zu verstehen, welche der Formel (A-I) entsprechen.Another particularly preferred group of ingredients in the cosmetic compositions of the invention are betaines. In particular, the betaines according to the invention are to be understood as meaning those which correspond to the formula (A-I).
Figure imgf000004_0001
Figure imgf000004_0001
Als Beispiele für erfindungsgemäß besonders geeignete Betaine der Formel (A-I) sind zu nennen: Carnitin, Carnitintartrat, Carnitin Magnesiumeitrat, Acetylcarnitin, Taurin, Taurinlysylat, Taurintartrat, Taurinornithat, Lysyltaurin und Ornithyltaurin, 1 ,1-Dimethyl-Prolin, Hercynin (N',N',N'-Trimethyl-L-histidinium-betain), Cholin, Cholinchlorid, Cholinbitartrat,Examples of particularly suitable betaines of the formula (AI) according to the invention are: carnitine, carnitine tartrate, carnitine magnesium citrate, acetylcarnitine, taurine, taurine lysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine, 1,1-dimethyl-proline, hercynine (N ', N ', N'-trimethyl-L-histidinium betaine), choline, choline chloride, choline bitartrate,
Cholindihydrogencitrat und die als Betain bezeichnete Verbindung N,N,N-trimethylglycin. Bevorzugt werden Carnitin, Taurin, Histidin, Cholin, Betain sowie deren Derivate verwendet. Dabei können die erfindungsgemäßen Zusammensetzungen sowohl eine Verbindung gemäß Formel (A-I) als auch mehrere, insbesondere zwei, Verbindungen der Formel (A-I) enthalten. In einer besonders bevorzugten Ausführungsform der Erfindung wird als Wirkstoff L-Carnitintartrat eingesetzt. In einer bevorzugten Ausführungsform enthält das kosmetische Mittel neben dem Cranberry-Extrakt noch Taurin und/oder mindestens eines seiner Derivate. In der vorliegenden Erfindung ist mit Taurin 2-Aminoethansulfonsäure gemeint. BevorzugteCholine dihydrogen citrate and the compound designated as betaine N, N, N-trimethylglycine. Carnitine, taurine, histidine, choline, betaine and their derivatives are preferably used. The compositions according to the invention may contain both a compound according to formula (AI) and several, in particular two, compounds of formula (AI). In a particularly preferred embodiment of the invention, the active ingredient used is L-carnitine tartrate. In a preferred embodiment, the cosmetic composition contains, in addition to the cranberry extract, taurine and / or at least one of its derivatives. In the present invention, by taurine is meant 2-aminoethanesulfonic acid. preferred
Taurinderivate sind N-Monomethyltaurin und N,N-Dimethyltaurin. Weitere Taurinderivate im Sinne der vorliegenden Erfindung sind die Taurocholsäure und Hypotaurin.Taurine derivatives are N-monomethyltaurine and N, N-dimethyltaurine. Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
In einer weiteren erfindungsgemäß bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen Biochinone, die als Coenzyme wirken. In den erfindungsgemäßen Mitteln sind unter geeigneten Biochinonen ein oder mehrere Ubichinon(e) und/oder Plastochinon(e) zu verstehen.In another preferred embodiment of the invention, the compositions of the invention contain biochinones which act as coenzymes. In the agents according to the invention, suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
Die erfindungsgemäß bevorzugten Ubichinone weisen die folgende Formel auf:The preferred ubiquinones according to the invention have the following formula:
Figure imgf000005_0001
10.
Figure imgf000005_0001
10th
In einer ganz besonders bevorzugten Ausführungsform der vorliegenden Erfindung enthält das kosmetische Mittel eine Kombination aus Coenzym Q-10 (Ubichinon-50) und/oder mindestens einem seiner Derivate und Cranberry-Extrakt.In a very particularly preferred embodiment of the present invention, the cosmetic agent contains a combination of coenzyme Q-10 (ubiquinone-50) and / or at least one of its derivatives and cranberry extract.
In einer weiteren bevorzugten Ausführungsform der vorliegenden Erfindung enthält das kosmetische Mittel eine Kombination aus Ectoin ((S)-2-Methyl-1 ,4,5,6-tetrahydro-4- pyrimidincarbonsäure) und/oder mindestens einem seiner Derivate und Cranberry-Extrakt. In einer weiteren bevorzugten Ausführungsform der vorliegenden Erfindung enthält das kosmetische Mittel eine Kombination aus Pantolacton ((R)-Dihydro-3-hydroxy-4,4-dimethyl-2(3H- furanon) und Cranberry-Extrakt. Ganz besonders bevorzugte Mittel im Sinne der vorliegenden Erfindung enthalten Pantolacton. In einer weiteren bevorzugten Ausführungsform der vorliegenden Erfindung enthält das kosmetische Mittel eine Kombination aus Pantothensäure und/oder mindestens einem seiner Derivate und Cranberry-Extrakt. Pantothensäure wird bevorzugt als Derivat in Form der stabileren Calciumsalze und Natriumsalze (Ca-Pantothenat, Na-Pantothenat) in der vorliegenden Erfindung eingesetzt. Weitere, im Rahmen der vorliegenden Erfindung geeignete Derivate der Pantothensäure sind Panthenol und Pantethein. Erfindungsgemäß besonders bevorzugt sind Mittel, die - bezogen auf ihr Gewicht - 0,00001 bis 10,0 Gew.-%, vorzugsweise 0,0001 bis 5,0 Gew.-%, der Wirkstoffe aus der Gruppe, die gebildet wird von Carnitintartrat, Coenzym Q-10, Ectoin, Pantolacton, Pantothensäure, Taurin und deren Derivaten, enthalten.In a further preferred embodiment of the present invention, the cosmetic composition contains a combination of ectoine ((S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid) and / or at least one of its derivatives and cranberry extract , In a further preferred embodiment of the present invention, the cosmetic composition contains a combination of pantolactone ((R) -dihydro-3-hydroxy-4,4-dimethyl-2 (3H-furanone) and cranberry extract In a further preferred embodiment of the present invention, the cosmetic composition comprises a combination of pantothenic acid and / or at least one of its derivatives and cranberry extract Pantothenic acid is preferred as a derivative in the form of the more stable calcium salts and sodium salts (Ca-pantothenate Other suitable pantothenic acid derivatives in the context of the present invention are panthenol and panthethein Particularly preferred according to the invention are agents which, based on their weight, have 0.00001 to 10.0 parts by weight. %, preferably 0.0001 to 5.0 wt .-%, of the active ingredients from the group formed by Car nitintartrate, co-enzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and their derivatives.
Die erfindungsgemäßen Mittel können Carnitin Tartrat, Coenzym Q-10, Ectoin, Pantolacton, Pantothensäure, Taurin und/oder deren Derivaten auch in Form von Naturstoffextrakten enthalten, die aus Naturstoffen gewonnen wurden, welche die entsprechenden Wirkstoffe oder deren Derivate enthalten. Es kann weiterhin besonders bevorzugt sein, wenn das erfindungsgemäße Mittel zusätzlich mindestens ein Konditioniermittel enthält. Bevorzugte Konditioniermittel werden ausgewählt aus der Gruppe, die aus kationischen Tensiden, kationischen Polymeren und Silikonen gebildet wird. In den erfindungsgemäßen Mitteln werden ganz besonders kationische Polymere als weitere Inhaltsstoffe verwendet. Bevorzugte kationische und kommerziell erhältliche Polymere sind beispielsweise quaternisierte Cellulose-Derivate, kationische Alkylpolyglycoside, kationisierter Honig, beispielsweise das Handelsprodukt Honeyquat® 50, kationische Guar-Derivate, polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden vonThe compositions according to the invention may also contain carnitine tartrate, coenzyme Q-10, ectoine, pantolactone, pantothenic acid, taurine and / or derivatives thereof in the form of natural product extracts obtained from natural products containing the corresponding active ingredients or their derivatives. It may furthermore be particularly preferred if the agent according to the invention additionally contains at least one conditioning agent. Preferred conditioning agents are selected from the group consisting of cationic surfactants, cationic polymers and silicones. Very particularly cationic polymers are used as further ingredients in the compositions according to the invention. Preferred cationic polymers are commercially available and, for example, quaternized cellulose derivatives, cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of
Acrylsäure und Methacrylsäure.Acrylic acid and methacrylic acid.
Copolymere des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats, wie beispielsweise mit Diethylsulfat quaternierte Vinylpyrrolidon-Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as vinylpyrrolidone quaternized with diethyl sulfate
Dimethylaminoethylmethacrylat-Copolymere.Dimethylaminoethyl methacrylate copolymers.
Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, quaternierter Polyvinylalkohol sowie die unter den Bezeichnungen Polyquaternium 2,Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers, quaternized polyvinyl alcohol and those under the names Polyquaternium 2,
Polyquaternium 17, Polyquaternium 18 und Polyquaternium 27 bekannten Polymeren mit quartären Stickstoffatomen in der Polymerhauptkette,Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain,
Vinylpyrrolidon-Vinylcaprolactam-Acrylat-Terpolymere,Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers,
Die kationischen Polymere sind in den erfindungsgemäßen Zusammensetzungen bevorzugt in Mengen von 0,05 bis 10 Gew.-%, bezogen auf das gesamte Mittel, enthalten. Mengen von 0,1 bis 5 Gew.-% sind besonders bevorzugt.The cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
Eine letzte Substanzgruppe, welche als Konditioniermittel in den erfindungsgemäßen Mitteln zusätzlich verwendet werden können, sind Silikonöle (im folgenden auch Silikone). In einer besonders bevorzugten Ausführungsform der vorliegenden Erfindung ist das Konditioniermittel ein konditionierendes Silikon mit einer Viskosität von 20.000 bis 120.000 mPa s, ganz besonders bevorzugt von 40.000 bis 80.000 mPa s.A last group of substances which can additionally be used as conditioning agents in the compositions according to the invention are silicone oils (in the following also silicones). In a particularly preferred embodiment of the present invention, the conditioning agent is a conditioning silicone having a viscosity of from 20,000 to 120,000 mPa s, most preferably from 40,000 to 80,000 mPa s.
Besonders bevorzugt ist das konditionierende Silikon ausgewählt aus Dimethiconen, Amodimethiconen oder Dimethiconolen.The conditioning silicone is particularly preferably selected from dimethicones, amodimethicones or dimethiconols.
Es kann erfindungsgemäß bevorzugt sein, das erfindungsgemäße Mittel im Rahmen einer Farbveränderung der Haare, zu verwenden. Insbesondere die oxidative Farbveränderung ist dabei bevorzugt, da die Pflegewirkung der erfindungsgemäßen Mittel auch bei Gegenwart eines Oxidationsmittels hervorragend ist.It may be preferred according to the invention to use the agent according to the invention in the context of a color change of the hair. In particular, the oxidative color change is preferred because the care effect of the compositions of the invention is excellent even in the presence of an oxidizing agent.
Zum Zweck der Farbveränderung enthalten die kosmetischen Mittel zusätzlich vorzugsweise mindestens eine farbverändernde Komponente. Gemäß Aufgabe wird u.a. die Echtheit der erzielten Färbung gegenüber Umwelteinflüssen verbessert. Die farbverändernde Komponente wird wiederum bevorzugt ausgewähltFor the purpose of color change, the cosmetic agents additionally preferably contain at least one color-modifying component. In accordance with the task, inter alia, the authenticity of the color obtained against environmental influences is improved. The color-changing component is again preferably selected
(a) aus mindestens einem Oxidationsfarbstoffvorprodukt vom Typ der Entwicklerkomponenten und gegebenenfalls zusätzlich mindestens einer Kupplerkomponente und/oder(A) from at least one oxidation dye precursor of the type of developer components and optionally additionally at least one coupler component and / or
(b) aus Oxofarbstoffvorprodukten und/oder(b) from oxo dye precursors and / or
(c) aus mindestens einem direktziehenden Farbstoff und/oder(c) from at least one direct dye and / or
(d) aus mindestens einer Vorstufe naturanaloger Farbstoffe und/oder(D) from at least one precursor of natural dyes and / or
(e) aus mindestens einem Bleichverstärker.(e) at least one bleach booster.
In einer besonders bevorzugten Ausführungsform der vorliegenden Erfindung enthält das kosmetische Mittel daher zusätzlich mindestens ein Oxidationsfarbstoffvorprodukt vom Typ der Entwicklerkomponenten.In a particularly preferred embodiment of the present invention, the cosmetic agent therefore additionally contains at least one oxidation dye precursor of the developer component type.
Das eigentliche oxidative Färbemittel wird bei getrennter Lagerung der Farbstoffvorprodukte und des Oxidationsmittels unmittelbar vor der Anwendung durch Mischen hergestellt. In einer bevorzugten Ausführungsform wird daher das kosmetische Mittel vor der Applikation aus einer Zusammensetzung, enthaltend in einem kosmetischen Träger mindestens eine farbverändernde Komponente, und einer weiteren Zusammensetzung, enthaltend in einem kosmetischen Träger mindestens ein Oxidationsmittel, gemischt.The actual oxidative colorant is prepared by separate storage of the dye precursors and the oxidizing agent immediately before use by mixing. In a preferred embodiment, the cosmetic agent is therefore mixed before application from a composition comprising at least one color-modifying component in a cosmetic carrier and a further composition containing at least one oxidizing agent in a cosmetic carrier.
Bei einer Anwendung von Oxidationsmitteln wird die anwendungsfertige Zubereitung zweckmäßigerweise unmittelbar vor der Anwendung durch Mischung einer Zusammensetzung, enthaltend das Oxidationsmittel mit der Zusammensetzung, enthaltend die farbverändernden Komponenten, hergestellt. Das dabei entstehende gebrauchsfertige Haarpräparat sollte bevorzugt einen pH-Wert im Bereich von 6 bis 12, insbesondere von pH 7,5 bis 10, aufweisen. Für eine Farbveränderung mittels Aufhellung bzw. Bleichung der Haare wird bevorzugt in den erfindungsgemäßen kosmetischen Mitteln neben den Oxidationsmitteln zusätzlich mindestens ein Bleichverstärker eingesetzt.When using oxidizing agents, the ready-to-use composition is conveniently prepared immediately prior to use by mixing a composition containing the oxidizing agent with the composition containing the color-changing components. The resulting ready-to-use hair preparation should preferably have a pH in the range from 6 to 12, in particular from pH 7.5 to 10. For a color change by means of brightening or bleaching of the hair, in addition to the oxidizing agents, at least one bleaching booster is preferably used in the cosmetic compositions according to the invention.
Bleichverstärker werden bevorzugt in Blondiermitteln zur Steigerung der Blondierwirkung des Oxidationsmittels, insbesondere des Wasserstoffperoxids, eingesetzt.Bleach boosters are preferably used in bleaching agents for increasing the bleaching action of the oxidizing agent, in particular the hydrogen peroxide.
Die Bleichverstärker sind in den erfindungsgemäßen, kosmetischen Mitteln bevorzugt in Mengen von 5 bis 30 Gew.-%, insbesondere in Mengen von 8 bis 20 Gew.-%, enthalten. Die kosmetischen Mittel der Erfindung enthalten, wenn sie als Bleichmittel fungieren, als bevorzugtes Alkalisierungsmittel mindestens eine Verbindung, ausgewählt aus Ammonium-, Alkalimetall- und Erdalkalimetallhydroxiden, -carbonaten, -hydrogencarbonaten, -hydroxycarbo- naten, -metasilikaten und -Carbamiden, sowie Alkaliphosphaten. Die in dem erfindungsgemäßen Verfahren eingesetzten kosmetischen Mittel können weiterhin alle für solche Zubereitungen bekannten Wirk-, Zusatz- und Hilfsstoffe enthalten: Das Nachwaschen mit einem Shampoo entfällt, wenn ein stark tensidhaltiger Träger verwendet wurde.The bleach boosters are present in the cosmetic agents according to the invention preferably in amounts of from 5 to 30% by weight, in particular in amounts of from 8 to 20% by weight. The cosmetic agents of the invention, when acting as a bleaching agent, contain as preferred alkalizing agent at least one compound selected from ammonium, alkali metal and alkaline earth metal hydroxides, carbonates, bicarbonates, hydroxycarboxylates, metasilicates and carbamides, as well as alkali phosphates. The cosmetic agents used in the process according to the invention may furthermore contain all active ingredients, additives and auxiliaries known for such preparations: Washing with a shampoo is unnecessary if a carrier which is highly surfactant-containing was used.
In vielen Fällen enthalten die Mittel mindestens eine oberflächenaktive Substanz, wobei prinzipiell sowohl anionische als auch zwitterionische, ampholytische, nichtionische und kationische oberflächenaktive Substanzen geeignet sind. Die Auswahl der oberflächenaktiven Substanzen richtet sich nach der Art des Mittels. Im Falle eines Shampoos wird insbesondere mindestens ein Tensid aus der Gruppe der anionischen, der zwitterionischen oder nichtionischen oberflächenaktiven Substanzen gewählt. Bevorzugt ist hierbei, dass mindestens eine anionische und mindestens eine zwitterionische oberflächenaktive Substanz gewählt wird. Besonders bevorzugt werden diese oberflächenaktiven Substanzen dabei aus der Gruppe der besonders milden oberflächenaktiven Substanzen gewählt. In vielen Fällen hat es sich aber als vorteilhaft erwiesen, die Tenside aus anionischen, zwitterionischen oder nichtionischen Tensiden auszuwählen. Dabei beträgt das Verhältnis zwischen anionischen und zwitterionischen oberflächenaktiven Substanzen zwischen 10 : 1 und 1 : 5. Besonders bevorzugt ist das Verhältnis 5 : 1 bis 1 : 2. Stellt das Mittel eine das Haar konditionierende Zusammensetzung dar, dann werden bevorzugt als oberflächenaktive Substanzen kationische und/oder nichtionische oberflächenaktive Substanzen ausgewählt. Auch hier wiederum ist eine Auswahl der sogenannten milden oberflächenaktiven Substanzen besonders bevorzugt.In many cases, the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle. The choice of surfactants depends on the nature of the agent. In the case of a shampoo, in particular at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen. These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants. The ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5. The ratio is particularly preferably 5: 1 to 1: 2. If the composition is a hair-conditioning composition, cationic surfactants are preferably used as surface-active substances or nonionic surfactants selected. Again, a selection of the so-called mild surface-active substances is particularly preferred.
Als anionische Tenside (Tanion) eignen sich in erfindungsgemäßen Zubereitungen alle für die Verwendung am menschlichen Körper geeigneten anionischen oberflächenaktiven Stoffe. Bevorzugte anionische Tenside sind Alkylsulfate, Alkylpolyglykolethersulfate und Ether- carbonsäuren mit 10 bis 18 C-Atomen in der Alkylgruppe und bis zu 12 Glykolethergruppen im Molekül, Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 18 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremono-alkylpolyoxyethylester mit 8 bis 18 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen, Monoglycerdisulfate, Alkyl- und Alkenyletherphosphate sowie Eiweissfettsäurekondensate.Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body. Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettsäurekondensate.
Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Alkyl-N,N- dimethylammonium-glycinate, beispielsweise das Kokosalkyl-dimethylammoniumglycinat, N-Acyl- aminopropyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosacylaminopropyl- dimethylammoniumglycinat, und 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarb- oxymethylglycinat. Ein bevorzugtes zwitterionisches Tensid ist das unter der INCI-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid-Derivat.Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
Beispiele für geeignete ampholytische Tenside sind N-Alkylglycine, N-Alkylpropionsäuren, N- Alkylaminobuttersäuren, N-Alkyliminodipropionsäuren, N-Hydroxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkylaminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 24 C-Atomen in der Alkylgruppe.Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic and Alkylaminoessigsäuren each having about 8 to 24 carbon atoms in the alkyl group.
Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropionat, das Kokos- acylaminoethylaminopropionat und das C12 - C18 - Acylsarcosin.Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
Als bevorzugte nichtionische Tenside haben sich die Alkylenoxid-Anlagerungsprodukte an gesättigte lineare Fettalkohole und Fettsäuren mit jeweils 2 bis 30 Mol Ethylenoxid pro Mol Fettalkohol bzw. Fettsäure sowie die Zuckertenside erwiesen. Zubereitungen mit hervorragenden Eigenschaften werden ebenfalls erhalten, wenn sie als nichtionische Tenside Fettsäureester von ethoxyliertem Glycerin enthalten.As preferred nonionic surfactants, the alkylene oxide adducts to saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid and the sugar surfactants have proven. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
Kationische, zwitterionische und/oder amphotere Tenside sowie deren Mischungen können erfindungsgemäß bevorzugt sein. Anionische Tenside werden insbesondere verwendet, wenn die erfindungsgemäßen Zusammensetzungen als Duschbäder verwendet werden sollen. Die Tenside (T) werden in Mengen von 0,05 - 45 Gew.-%, bevorzugt 0,1 - 30 Gew.-% und ganz besonders bevorzugt von 0,5 - 25 Gew.-%, bezogen auf das gesamte erfindungsgemäß verwendete Mittel, eingesetzt. Erfindungsgemäß verwendbare Emulgatoren sind beispielsweiseCationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention. Anionic surfactants are used in particular when the compositions according to the invention are to be used as shower baths. The surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total amount used in accordance with the invention Medium, used. Emulsifiers which can be used according to the invention are, for example
Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Pro pylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und anAddition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles per propylene oxide to linear fatty alcohols having 8 to 22 carbon atoms, to fatty acids having 12 to 22 carbon atoms and on
Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,Alkylphenols having 8 to 15 C atoms in the alkyl group,
C12-C22-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Polyole mit 3 bis 6 Kohlenstoffatomen, insbesondere an Glycerin,C 12 -C 22 fatty acid mono- and diesters of addition products of from 1 to 30 moles of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,
Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester,Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters,
Fettsäurealkanolamide und Fettsäureglucamide,Fatty acid alkanolamides and fatty acid glucamides,
C8-C22-Alkylmono- und -oligoglycoside und deren ethoxylierte Analoga,C 8 -C 22 alkyl mono- and oligoglycosides and their ethoxylated analogs,
Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen zum Beispiel das im Handel erhältliche Produkt Montanov®68,Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ® Montanov 68,
Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,Addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
Partialester von Polyolen mit 3-6 Kohlenstoffatomen mit gesättigten Fettsäuren mit 8 bis 22Partial esters of polyols of 3-6 carbon atoms with saturated fatty acids of 8 to 22
C-Atomen,C-atoms,
Sterine. Als Sterine wird eine Gruppe von Steroiden verstanden, die am C-Atom 3 desSterols. Sterols are understood to mean a group of steroids which bind to C-atom 3 of the
Steroid-Gerüstes eine Hydroxylgruppe tragen und sowohl aus tierischem GewebeSteroid scaffold carry a hydroxyl group and both from animal tissue
(Zoosterine) wie auch aus pflanzlichen Fetten (Phytosterine) isoliert werden.(Zoosterine) as well as vegetable fats (phytosterols) are isolated.
Phospholipide. Hierunter werden vor allem die Glucose-Phospolipide, die z.B. als Lecithine bzw. Phospahtidylcholine aus z.B. Eidotter oder Pflanzensamen (z.B. Sojabohnen) gewonnen werden, verstanden.Phospholipids. Of these, especially the glucose phospholipids, e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
Fettsäureester von Zuckern und Zuckeralkoholen, wie Sorbit, Polyglycerine und Polyglycerinderivate wie beispielsweise Polyglycerinpoly-12-hydroxystearat (Handelsprodukt Dehymuls® PGPH),Fatty acid esters of sugars and sugar alcohols, such as sorbitol, Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
Lineare und verzweigte Fettsäuren mit 8 bis 30 C - Atomen und deren Na-, K-, Ammonium-, Ca-, Mg- und Zn - Salze. Die erfindungsgemäßen Mittel enthalten die Emulgatoren bevorzugt in Mengen von 0,1 - 25 bew.-0/o insbesondere 0,5 - 15 Gew.-%, bezogen auf das gesamte Mittel.Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts. The compositions of the invention preferably contain the emulsifiers in quantities of 0.1 to 25 bew.- 0 / o in particular 0.5 to 15 wt .-%, based on the total agent.
Amphotere Polymere sind ebenso wie die kationischen Polymere erfindungsgemäß ganz besonders bevorzugte Polymere. Unter dem Begriff amphotere Polymere werden sowohl solche Polymere, die im Molekül sowohl freie Aminogruppen als auch freie -COOH- oder SO3H-Gruppen enthalten und zur Ausbildung innerer Salze befähigt sind, als auch zwitterionische Polymere, die im Molekül quartäre Ammoniumgruppen und -COO - oder -SO3 "-Gruppen enthalten, und solche Polymere zusammengefaßt, die -COOH- oder SO3H-Gruppen und quartäre Ammoniumgruppen enthalten.Amphoteric polymers as well as the cationic polymers according to the invention are very particularly preferred polymers. The term amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO 3 H groups and are capable of forming internal salts, as well as zwitterionic polymers which in the molecule have quaternary ammonium groups and -COO or -SO 3 " groups, and those polymers comprising -COOH or SO 3 H groups and quaternary ammonium groups.
Die amphoteren Polymere sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05 bis 10 Gew.-%, bezogen auf das gesamte Mittel, enthalten. Mengen von 0,1 bis 5 Gew.-% sind besonders bevorzugt.The amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
Bei den anionischen Polymeren handelt es sich um anionische Polymere, welche Carboxylat- und/oder Sulfonatgruppen aufweisen. Beispiele für anionische Monomere, aus denen derartige Polymere bestehen können, sind Acrylsäure, Methacrylsäure, Crotonsäure, Maleinsäureanhydrid und 2-Acrylamido-2-methylpropansulfonsäure. Dabei können die sauren Gruppen ganz oder teilweise als Natrium-, Kalium-, Ammonium-, Mono- oder Triethanolammonium-Salz vorliegen. Bevorzugte Monomere sind 2-Acrylamido-2-methylpropansulfonsäure und Acrylsäure. Als ganz besonders wirkungsvoll haben sich anionische Polymere erwiesen, die als alleiniges oder Co-Monomer 2-Acrylamido-2-methylpropansulfonsäure enthalten, wobei die Sulfonsäuregruppe ganz oder teilweise als Natrium-, Kalium-, Ammonium-, Mono- oder Triethanolammonium-Salz vorliegen kann. Besonders bevorzugt ist das Homopolymer der 2- Acrylamido-2-methylpropansulfon-säure, das beispielsweise unter der Bezeichnung Rheothik®11- 80 im Handel erhältlich ist.The anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid. Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt , Particularly preferred is the homopolymer of 2-acrylamido-2-methylpropanesulfonic acid, which is commercially available, for example, under the name Rheothik®11-80.
Die anionischen Polymere sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05 bis 10 Gew.-%, bezogen auf das gesamte Mittel, enthalten. Mengen von 0,1 bis 5 Gew.-% sind besonders bevorzugt.The anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
Die erfindungsgemäßen Mittel können in einer weiteren Ausführungsform nichtionogene Polymere enthalten.In a further embodiment, the agents according to the invention may contain nonionogenic polymers.
Die nichtionischen Polymere sind in den erfindungsgemäßen Zusammensetzungen bevorzugt in Mengen von 0,05 bis 10 Gew.-%, bezogen auf das gesamte Mittel, enthalten. Mengen von 0,1 bis 5 Gew.-% sind besonders bevorzugt. Die Polymere (P) sind in den erfindungsgemäß verwendeten Zusammensetzungen bevorzugt in Mengen von 0,01 bis 30 Gew.-%, bezogen auf die gesamte Zusammensetzung, enthalten. Mengen von 0,01 bis 25, insbesondere von 0,01 bis 15 Gew.-%, sind besonders bevorzugt. Ein weiterer erfindungsgemäßer synergistischer Wirkstoff in den erfindungsgemäßen Zusammensetzungen mit dem erfindungsgemäßen Wirkstoffkomplex sind Proteinhydrolysate und/oder dessen Derivate (P).The nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred. The polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred. Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).
Unter dem Begriff Proteinhydrolysate werden erfindungsgemäß auch Totalhydrolysate sowie einzelne Aminosäuren und deren Derivate sowie Gemische aus verschiedenen Aminosäuren verstanden. Weiterhin werden erfindungsgemäß aus Aminosäuren und Aminosäurederivaten aufgebaute Polymere unter dem Begriff Proteinhydrolysate verstanden. Zu letzteren sind beispielsweise Polyalanin, Polyasparagin, Polyserin etc. zu zählen. Weitere Beispiele für erfindungsgemäß einsetzbare Verbindungen sind L-Alanyl-L-prolin, Polyglycin, Glycyl-L-glutamin oder D/L-Methionin-S-Methylsulfoniumchlorid. Selbstverständlich können erfindungsgemäß auch ß- Aminosäuren und deren Derivate wie ß-Alanin, Anthranilsäure oder Hippursäure eingesetzt werden. Das Molgewicht der erfindungsgemäß einsetzbaren Proteinhydrolysate liegt zwischen 75, dem Molgewicht für Glycin, und 200000, bevorzugt beträgt das Molgewicht 75 bis 50000 und ganz besonders bevorzugt 75 bis 20000 Dalton.According to the invention, the term protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids. Furthermore, according to the invention, polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates. The latter include, for example, polyalanine, polyasparagine, polyserine, etc. Further examples of compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride. Of course, according to the invention, β-amino acids and their derivatives such as β-alanine, anthranilic acid or hippuric acid can also be used. The molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
Erfindungsgemäß können Proteinhydrolysate sowohl pflanzlichen als auch tierischen oder marinen oder synthetischen Ursprungs eingesetzt werden. Tierische Proteinhydrolysate sind beispielsweise Elastin-, Kollagen-, Keratin-, Seiden- und Milcheiweiß-Proteinhydrolysate, die auch in Form von Salzen vorliegen können. Solche Produkte werden beispielsweise unter den Warenzeichen Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (Deutsche Gelatine Fabriken Stoess & Co), Lexein® (Inolex) und Kerasol® (Croda) vertrieben. Weiterhin sind erfindungsgemäß bevorzugt pflanzliche Proteinhydrolysate wie beispielsweise Moringa-, Soja-, Mandel-, Erbsen-, Kartoffel- und Weizenproteinhydrolysate. Solche Produkte sind beispielsweise unter den Warenzeichen Puricare® LS 9658 (Laboratoires Serobiologiques), Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy® (Croda), Hydrolupin® (Croda), Hydrosesame® (Croda), Hydrotritium® (Croda) und Crotein® (Croda) erhältlich. Weitere erfindungsgemäß bevorzugte Proteinhydrolysate sind maritimen Ursprunges. Hierzu zählen beispielsweise Kollagenhydrolysate von Fischen oder Algen sowie Proteinhydrolysate von Muscheln bzw. Perlenextrakten.According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used. Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are sold, for example, under the trademarks Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (German Gelatin Factories Stoess & Co), Lexein® (Inolex) and Kerasol® (Croda). Furthermore, vegetable protein hydrolysates such as moringa, soybean, almond, pea, potato and wheat protein hydrolysates are preferred according to the invention. Such products are available, for example, under the trademarks Puricare® LS 9658 (Laboratories Serobiologiques), Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy® (Croda), Hydrolupin® (Croda), Hydrosesame® (Croda ), Hydrotritium® (Croda) and Crotein® (Croda). Further preferred protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl extracts.
Die Proteinhydrolysate (P) sind in den Zusammensetzungen in Konzentrationen von 0,001 Gew.- % bis zu 20 Gew.-%, vorzugsweise von 0,05 Gew.-% bis zu 15 Gew.-% und ganz besonders bevorzugt in Mengen von 0,05 Gew.-% bis zu 5 Gew.-% enthalten.The protein hydrolysates (P) are present in the compositions at levels of from 0.001% to 20% by weight, preferably from 0.05% to 15% by weight, and most preferably in amounts of 0, 05 wt .-% up to 5 wt .-% included.
Die Wirkung der erfindungsgemäßen Zusammensetzungen kann weiterhin durch eine 2- Pyrrolidinon-5-carbonsäure und deren Derivate (J) gesteigert werden. Bevorzugt sind die Natrium-, Kalium-, Calcium-, Magnesium- oder Ammoniumsalze, bei denen das Ammoniumion neben Wasserstoff eine bis drei C1- bis C4-Alkylgruppen trägt. Das Natriumsalz ist ganz besonders bevorzugt. Die eingesetzten Mengen in den erfindungsgemäßen Mitteln betragen 0,05 bis 10 Gew.-%, bezogen auf das gesamte Mittel, besonders bevorzugt 0,1 bis 5, und insbesondere 0,1 bis 3 Gew.-%.The effect of the compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J). Preferred are the Sodium, potassium, calcium, magnesium or ammonium salts, in which the ammonium ion in addition to hydrogen carries one to three C1 to C4 alkyl groups. The sodium salt is most preferred. The amounts used in the inventive compositions are 0.05 to 10 wt .-%, based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt .-%.
Eine weitere bevorzugte Gruppe von Inhaltsstoffen der erfindungsgemäßen Zusammensetzungen mit dem erfindungsgemäßen Wirkstoffkomplex sind Vitamine, Provitamine oder Vitaminvorstufen. Vitamine, Pro-Vitamine und Vitaminvorstufen sind dabei besonders bevorzugt, die den Gruppen A, B, C, E, F und H zugeordnet werden.Another preferred group of ingredients of the compositions according to the invention with the active ingredient complex according to the invention are vitamins, provitamins or vitamin precursors. Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
Die erfindungsgemäßen Zusammensetzungen können zusätzlich antimikrobielle Verbindungen enthalten. Geeignete antimikrobielle Verbindungen sind z. B. kationische oberflächenaktive Stoffe wie z. B. Cetyltrimethylammoniumbromid, Benzethoniumchlorid, Cetylpyridiniumchlorid oder das als Aminfluorid bekannte N,N,N'-tris-(2-Hydroxyethyl)-N'-octadecyl-1 ,3-diaminopropan- dihydrofluorid. Gut eignen sich auch die antimikrobiell wirksamen Biguanidverbindungen wie z. B. das Polyhexamethylenbiguanid (Vantocil® IB, ICI) oder das 1 ,1 '-Hexamethylen-bis-(4- Chlorphenyl)-biguanid ("Chlorhexidin") in Form eines wasserlöslichen, verträglichen Salzes, z. B. in Form des Acetats oder Gluconats. Bevorzugt eignen sich auch die antimikrobiellen 5-Amino- hexahydropyrimidine, z. B. das 1 ,3-Bis-(2-ethylhexyl)-5-methyl-5-amino-hexahydropyrimidin ("Hexetidin"). Weitere bevorzugt geeignete antimikrobielle Wirkstoffe sind die nichtkationischen, phenolischen, antimikrobiellen Stoffe, insbesondere die halogenierten Phenole und Diphenylether. Besonders geeignete antimikrobielle Verbindungen dieses Types sind z. B. das 6,6'- Methylen-Bis-(2-brom-4-chlorphenol) ("Bromchlorophen") und der 2,4,4'-Trichlor-2'-hydroxy- diphenylether ("Triclosan").The compositions according to the invention may additionally contain antimicrobial compounds. Suitable antimicrobial compounds are, for. B. cationic surfactants such. B. cetyl trimethyl ammonium bromide, benzethonium chloride, cetylpyridinium chloride or fluoride, known as amine N, N, N 'tris (2-hydroxyethyl) -N' -octadecyl-1, 3-diaminopropan- dihydrofluoride. Good are also the antimicrobial biguanide compounds such. B. the polyhexamethylene biguanide (Vantocil® IB, ICI) or the 1, 1 ' hexamethylene bis (4-chlorophenyl) biguanide ("chlorhexidine") in the form of a water-soluble, compatible salt, e.g. In the form of the acetate or gluconate. Preferably, the antimicrobial 5-amino-hexahydropyrimidines, z. For example, the 1, 3-bis (2-ethylhexyl) -5-methyl-5-amino-hexahydropyrimidine ("hexetidine"). Further preferably suitable antimicrobial agents are the non-cationic, phenolic, antimicrobial substances, in particular the halogenated phenols and diphenyl ethers. Particularly suitable antimicrobial compounds of this type are z. B. the 6,6 ' - methylene-bis- (2-bromo-4-chlorophenol) ("bromochlorophene") and the 2,4,4 ' trichloro-2 ' hydroxy-diphenyl ether ("Triclosan").
Weitere geeignete antimikrobielle Stoffe sind die p-Hydroxybenzoesäureester und Sesquiterpenalkohole wie z. B. das Bisabolol, das Farnesol, das Santalol oder das Nerolidol. Als weiteren bevorzugten Inhaltsstoff können die erfindungsgemäßen Mittel Purin und/oder Derivat(e) des Purins enthalten. Purine und Purinderivate werden oft aus Naturstoffen isoliert, sind aber auch auf vielen Wegen synthetisch zugänglich.Further suitable antimicrobial substances are the p-hydroxybenzoic acid esters and sesquiterpene alcohols such. As the bisabolol, farnesol, Santalol or Nerolidol. As a further preferred ingredient, the agents according to the invention may contain purine and / or derivative (s) of the purine. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
Erfindungsgemäß bevorzugte kosmetische Mittel sind dadurch gekennzeichnet, dass sie Purin und/oder Purinderivat(e) der Formel (I) bzw. (II) enthaltenCosmetic agents preferred according to the invention are characterized in that they contain purine and / or purine derivative (s) of the formula (I) or (II)
Figure imgf000012_0001
in der die Reste R1 , R2 und R3 der Formel (I) unabhängig voneinander ausgewählt sind aus -H, - OH, -NH2, -SH und die Reste R4, R5 und R6 der Formel (II) unabhängig voneinander ausgewählt sind aus -H, -CH3 und -CH2-CH3 substituiert sind, wobei folgende Verbindungen gemäß Formel (I):
Figure imgf000012_0001
in which the radicals R 1 , R 2 and R 3 of the formula (I) are selected independently of one another from -H, - OH, -NH 2 , -SH and the radicals R4, R5 and R6 of the formula (II) independently of one another are selected from -H, -CH 3 and -CH 2 -CH 3 are substituted, where the following compounds according to formula (I):
- Purin (R1 = R2 = R3 = H)Purine (R1 = R2 = R3 = H)
- Adenin (R1 = NH2, R2 = R3 = H)- adenine (R1 = NH2, R2 = R3 = H)
- Guanin (R1 = OH, R2 = NH2, R3 = H)- guanine (R1 = OH, R2 = NH2, R3 = H)
- Harnsäure (R1 = R2 = R3 = OH)- uric acid (R1 = R2 = R3 = OH)
- Hypoxanthin (R1 = OH, R2 = R3 = H)Hypoxanthine (R1 = OH, R2 = R3 = H)
- 6-Purinthiol (R1 = SH, R2 = R3 = H)6-Purethiol (R1 = SH, R2 = R3 = H)
- 6-Thioguanin (R1 = SH, R2 = NH2, R3 = H)- 6-thioguanine (R1 = SH, R 2 = NH 2, R3 = H)
- Xanthin (R1 = R2 = OH, R3 = H) und folgende Verbindungen gemäß Formel (II):Xanthine (R1 = R2 = OH, R3 = H) and the following compounds according to formula (II):
- Coffein (R4 = R5 = R6 = CH3)- caffeine (R4 = R5 = R6 = CH3)
- Theobromin (R4 = H, R5 = R6 = CH3)- theobromine (R4 = H, R5 = R6 = CH3)
- Theophyllin (R4 = R5 = CH3, R6 = H) bevorzugt sind.- Theophylline (R4 = R5 = CH3, R6 = H) are preferred.
In haarkosmetischen Formulierungen hat sich insbesondere Coffein bewährt, das beispielsweise in Shampoos, Conditionern, Haarwässern und/oder Lotionen vorzugsweise in Mengen von 0,005 bis 0,25 Gew.-%, weiter bevorzugt von 0,01 bis 0,1 Gew.-% und insbesondere von 0,01 bis 0,05 Gew.-% (jeweils bezogen auf das Mittel) eingesetzt werden kann.Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the agent) can be used.
Zusätzlich kann es sich als vorteilhaft erweisen, wenn in den erfindungsgemäßen Zusammensetzungen Penetrationshilfsstoffe und/ oder Quellmittel (M) enthalten sind. Hierzu sind beispielsweise zu zählen Harnstoff und Harnstoffderivate, Guanidin und dessen Derivate, Arginin und dessen Derivate, Wasserglas, Imidazol und Dessen Derivate, Histidin und dessen Derivate, Benzylalkohol, Glycerin, Glykol und Glykolether, Propylenglykol und Propylenglykolether, beispielsweise Propylenglykolmonoethylether, Carbonate, Hydrogencarbonate, Diole und Triole, und insbesondere 1 ,2-Diole und 1 ,3-Diole wie beispielsweise 1 ,2-Propandiol, 1 ,2-Pentandiol, 1 ,2- Hexandiol, 1 ,2-Dodecandiol, 1 ,3-Propandiol, 1 ,6-Hexandiol, 1 ,5-Pentandiol, 1 ,4-Butandiol. Eine besonders bevorzugte Gruppe von Quellmitteln können Hydantoine sein. Unabhängig davon, ob Hydantoin oder Hydantoinderivat(e) eingesetzt wird/werden, sind Einsatzmengen von 0,02 bis 2,5 Gew.-% ganz besonders bevorzugt, von 0,05 bis 1 ,5 Gew.-%, weiter bevorzugt 0,075 bis 1 Gew.-% und insbesondere 0,1 bis 0,25 Gew.-% - jeweils bezogen auf das gesamte Mittel - höchst bevorzugt.In addition, it may prove advantageous if the compositions according to the invention contain penetration aids and / or swelling agents (M). These include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1 , 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol. A particularly preferred group of swelling agents may be hydantoins. Regardless of whether hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
Weiterhin können die erfindungsgemäßen kosmetischen Zusammensetzungen pharmakologisch wirksame Substanzen enthalten. Beispiele für pharmakologisch wirksame Substanzen sind Corticosteroide, ß-Blocker, Östrogene, Phytoöstrogene, Cyproteronacetat, vasodilatorisch wirkende Substanzen wie Diazoxid, Nifedipin und Minoxidil, Acetylsalicylsäure oder Salicylsäure. Diese Substanzen sind in Mengen von 0,01 bis zu 10 Gew.-% jeweils bezogen auf die gesamte Zusammensetzung enthalten.Furthermore, the cosmetic compositions of the invention may contain pharmacologically active substances. Examples of pharmacologically active substances are corticosteroids, β-blockers, estrogens, phytoestrogens, cyproterone acetate, vasodilating substances such as diazoxide, nifedipine and minoxidil, acetylsalicylic acid or salicylic acid. These substances are contained in amounts of from 0.01 to 10% by weight, based in each case on the entire composition.
In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen einen Bitterstoff, um ein Herunterschlucken bzw. eine akzidentelle Ingestion zu verhindern. Dabei sind erfindungsgemäß Bitterstoffe bevorzugt, die in Wasser bei 20 0C zu mindestens 5 g/l löslich sind. Erfindungsgemäß hervorragend geeignet als Bitterstoffe sind quartäre Ammoniumverbindungen, die sowohl im Kation als auch im Anion eine aromatische Gruppe enthalten. Eine solche Verbindung ist das kommerziell z.B. unter den Warenzeichen Bitrex® und Indige-stin® erhältliche Benzyldiethyl((2,6-Xylylcarbamoyl)methyl)ammoniumbenzoat. Diese Verbindung ist auch unter der Bezeichnung Denatonium Benzoate bekannt. Der Bitterstoff ist in den erfindungsgemäßen Zusammensetzungen in Mengen von 0,0005 bis 0,1 Gew.-%, bezogen auf die Zusammensetzung enthalten. Besonders bevorzugt sind Mengen von 0,001 bis 0,05 Gew.-%.In a preferred embodiment, the compositions of the invention contain a bittering agent to prevent swallowing or accidental ingestion. Bitter substances which are soluble in water at 20 ° C. to at least 5 g / l are preferred according to the invention. Quaternary ammonium compounds which contain an aromatic group both in the cation and in the anion are outstandingly suitable as bitter substances. One such compound is benzyldiethyl ((2,6-xylylcarbamoyl) methyl) ammonium benzoate commercially available, for example, under the trade names Bitrex® and Indigo-stin®. This compound is also known by the name Denatonium Benzoate. The bittering agent is contained in the compositions of the invention in amounts of 0.0005 to 0.1 wt .-%, based on the composition. Particular preference is given to amounts of from 0.001 to 0.05% by weight.
Ferner können die kosmetischen Mittel weitere Wirk-, Hilfs- und Zusatzstoffe enthalten, wie beispielsweiseFurthermore, the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
Farbstoffe zum Anfärben des Mittels,Dyes for staining the agent,
Antischuppenwirkstoffe wie Piroctone Olamine, Zink Omadine und Climbazol,Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
Cholesterin,Cholesterol,
Komplexbildner wie EDTA, NTA, ß-Alanindiessigsäure und Phosphonsäuren,Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,
Trübungsmittel wie Latex, Styrol/PVP- und Styrol/Acrylamid-CopolymereOpacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
Perlglanzmittel wie Ethylenglykolmono- und -distearat sowie PEG-3-distearat,Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
Pigmente,pigments
Stabilisierungsmittel für Wasserstoffperoxid und andere Oxidationsmittel,Stabilizing agent for hydrogen peroxide and other oxidizing agents,
Treibmittel wie Propan-Butan-Gemische, N2O, Dimethylether, CO2 und Luft,Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
Antioxidantien.Antioxidants.
Der pH-Wert der erfindungsgemäßen Mittel liegt vorzugsweise zwischen 2 und 12. Die Einstellung des pH - Wertes der erfindungsgemäßen kosmetischen Zusammensetzungen erfolgt Verwendung der oben ausgeführten Carbonsäuren oder Mineralsäuren wie Phosphorsäure, Schwefelsäure usw.. Als Alkalisierungsmittel sind anorganische Verbindungen, vorzugsweise Hydroxide oder Ammoniak sowie organische Basen, vorzugsweise Amine und darunter insbesondere Alkanolamine, einsetzbar.The pH of the compositions according to the invention is preferably between 2 and 12. The adjustment of the pH of the cosmetic compositions according to the invention is carried out using the carboxylic acids or mineral acids such as phosphoric acid, sulfuric acid, etc .. The alkalizing agents are inorganic compounds, preferably hydroxides or ammonia and organic bases, preferably amines and including in particular alkanolamines, can be used.
Bevorzugte erfindungsgemäße Mittel enthalten in einem kosmetischen Träger neben einem Cranberry-Extrakt zusätzlich eine der folgenden Wirkstoffkombinationen (xiii) bis (xx): (xiii) Pantolacton und mindestens ein kationisches Tensid, (xiv) Pantolacton und mindestens ein kationisches Polymer, (xv) Pantolacton und mindestens ein Silikon, (xvi) Pantolacton und mindestens ein UV-Absorptionsmittel, (xvii) Ectoin und mindestens ein kationisches Tensid, (xviii) Ectoin und mindestens ein kationisches Polymer,Preferred agents according to the invention additionally comprise, in addition to a cranberry extract, in one cosmetic carrier one of the following active ingredient combinations (xiii) to (xx): (xiii) pantolactone and at least one cationic surfactant, (xiv) pantolactone and at least one cationic polymer, (xv) pantolactone and at least one silicone, (xvi) pantolactone and at least one UV absorber, (xvii) ectoine and at least one cationic surfactant, (xviii) ectoine and at least one cationic polymer,
(xix) Ectoin und mindestens ein Silikon,(xix) ectoine and at least one silicone,
(xx) Ectoin und mindestens ein UV-Absorptionsmittel.(xx) ectoine and at least one UV absorber.
Ein zweiter Erfindungsgegenstand ist daher ein Verfahren zur Behandlung keratinischer Fasern, in dem eine kosmetische Zusammensetzung, enthaltend in einem kosmetischen Träger einenA second subject of the invention is therefore a process for the treatment of keratinic fibers, in which a cosmetic composition containing in a cosmetic carrier a
Cranberry-Extrakt, aufgetragen und gegebenenfalls nach einer Einwirkungszeit wieder abgespült wird.Cranberry extract, applied and optionally rinsed again after an exposure time.
Die Einwirkungszeit des Cranberry-Extrakts beträgt bevorzugt wenige Sekunden bis 100 Minuten, besonders bevorzugt wenige Sekunden bis 45 Minuten und ganz besonders bevorzugt 1 bis 30The exposure time of the cranberry extract is preferably a few seconds to 100 minutes, more preferably a few seconds to 45 minutes and most preferably 1 to 30
Minuten.Minutes.
Eine bevorzugte Ausführungsform der vorliegenden Erfindung ist ein Verfahren zur oxidativenA preferred embodiment of the present invention is a process for oxidative
Haarbehandlung, in dem ein oxidatives kosmetisches Mittel, enthaltend in einem kosmetischenHair treatment in which an oxidative cosmetic agent containing in a cosmetic
Träger mindestens ein Oxidationsmittel auf das Haar aufgetragen wird und nach einerCarrier at least one oxidizing agent is applied to the hair and after a
Einwirkungszeit vom Haar gespült wird, wobei unmittelbar vor dem Auftragen des oxidativen kosmetischen Mittels ein kosmetisches Mittel, enthaltend in einem kosmetischen Träger einenIs rinsed from the hair, wherein immediately before the application of the oxidative cosmetic agent, a cosmetic agent containing in a cosmetic carrier
Cranberry-Extrakt, aufgetragen und gegebenenfalls nach einer Einwirkungszeit wieder abgespült wird.Cranberry extract, applied and optionally rinsed again after an exposure time.
Es ist wiederum erfindungsgemäß bevorzugt das erfindungsgemäße Verfahren im Rahmen einer oxidativen Haarfärbung, der oxidativen Haarbleiche oder der Fixierung im Rahmen einerIt is again preferred according to the invention, the method according to the invention in the context of an oxidative hair coloring, oxidative hair bleaching or fixation in the context of a
Dauerwelle anzuwenden. Dabei ist es bevorzugt, den Cranberry-Extrakt gemeinsam mit demApply perm. It is preferred, the cranberry extract together with the
Oxidationsmittel auf dem Haar anzuwenden.Apply oxidizer on the hair.
In einer bevorzugten Ausführungsform des erfindungsgemäßen Verfahrens als oxidativesIn a preferred embodiment of the process according to the invention as oxidative
Haarfärbeverfahren, wird bevorzugt der Cranberry-Extrakt als Bestandteil eines kosmetischenHair dyeing process, is preferred the cranberry extract as part of a cosmetic
Mittels enthaltend in einem kosmetischen Träger zusätzlich mindestens ein Oxidationsmittel und mindestens ein Oxidationsfarbstoffvorprodukt in einem Schritt angewendet.By means of containing in a cosmetic carrier additionally at least one oxidizing agent and at least one oxidation dye precursor applied in one step.
Die oxidativen Haarfärbemittel dieser Ausführungsform sind bevorzugt Zweikomponenten Mittel.The oxidative hair dyes of this embodiment are preferably two-component agents.
Die erste Komponente enthält in einem kosmetischen Träger einen Cranberry-Extrakt und mindestens ein Oxidationsfarbstoffvorprodukt. Die zweite Komponente enthält in einem kosmetischen Träger mindestens ein Oxidationsmittel. Diese Komponenten werden bevorzugt getrennt voneinander in jeweils einem Kompartiment konfektioniert und gemeinsam in einerThe first component contains in a cosmetic carrier a cranberry extract and at least one oxidation dye precursor. The second component contains at least one oxidizing agent in a cosmetic carrier. These components are preferably packaged separately in each case in a compartment and together in one
Verpackungseinheit (Kit) bereitgestellt. Kurz vor der Anwendung werden beide Komponenten miteinander vermischt.Packing unit (kit) provided. Shortly before use, both components are mixed together.
In der Ausführungsform des erfindungsgemäßen Verfahrens als oxidatives Haarbleichverfahren wird bevorzugt der Cranberry-Extrakt als Bestandteil eines kosmetischen Mittels enthaltend in einem kosmetischen Träger zusätzlich mindestens ein Oxidationsmittel und mindestens einenIn the embodiment of the method according to the invention as an oxidative hair bleaching method is preferably the cranberry extract as a component of a cosmetic agent containing in a cosmetic carrier additionally at least one oxidizing agent and at least one
Bleichverstärker in einem Schritt angewendet. Die oxidativen Haarbleichmittel dieser Ausführungsform sind bevorzugt Zwei- oder Dreikomponenten-Mittel. Die erste Komponente enthält in einem kosmetischen Träger ein Cranberry-Extrakt und gegebenenfalls mindestens einen Bleichverstärker. Der Bleichverstärker kann auch getrennt von dem Cranberry-Extrakt konfektioniert sein, beispielsweise in Pulverform, als wasserfreie Paste oder wasserfreies Öl. Dadurch wird ein Dreikomponenten-Mittel erhalten. Die letzte Komponente enthält in einem kosmetischen Träger mindestens ein Oxidationsmittel. Alle Komponenten werden bevorzugt getrennt voneinander in jeweils einem Kompartiment konfektioniert und gemeinsam in einer Verpackungseinheit (Kit) bereitgestellt. Kurz vor der Anwendung werden alle Komponenten miteinander gemischt.Bleach booster applied in one step. The oxidative hair bleaches of this embodiment are preferably two- or three-component agents. The first component contains in a cosmetic carrier a cranberry extract and optionally at least one bleach booster. The bleach booster may also be formulated separately from the cranberry extract, for example in powder form, as an anhydrous paste or an anhydrous oil. Thereby, a three-component agent is obtained. The last component contains at least one oxidizing agent in a cosmetic carrier. All components are preferably packaged separately in each case in a compartment and provided together in a packaging unit (kit). Just before use, all components are mixed together.
Die zuvor beschriebenen Mehrkomponentenmittel zur Durchführung des erfindungsgemäßen Verfahrens können in einer Verpackungseinheit bereitgestellt werden. Die Verpackungseinheit kann mindestens entweder einen Kontainer umfassen, der das Mittel des zweiten Erfindungsgegenstandes enthält, oder kann mindestens zwei Kontainer umfassen, wobei ein erster Kontainer ein oxidatives kosmetisches Mittel, enthaltend in einem kosmetischen Träger mindestens ein Oxidationsmittel, enthält, ein zweiter Kontainer ein kosmetische Mittel, enthaltend in einem kosmetischen Träger ein Cranberry-Extrakt, enthält und gegebenenfalls ein dritter Kontainer, der mindestens einen Bleichverstärker, eingebettet in einem kosmetischen Träger, enthält. Alle Kontainer können auch Kammern eines Mehrkammerbehältnisses sein. Für den zweiten Erfindungsgegenstand gilt mutatis mutandis das für den ersten Erfindungsgegenstand Gesagte.The multi-component means described above for carrying out the method according to the invention can be provided in a packaging unit. The packaging unit may comprise at least either a container containing the agent of the second subject of the invention or may comprise at least two containers, a first container containing an oxidative cosmetic agent containing at least one oxidizing agent in a cosmetic carrier, a second container containing a cosmetic agent containing in a cosmetic carrier a cranberry extract, and optionally a third container containing at least one bleach booster embedded in a cosmetic carrier. All Kontainer can also be chambers of a multi-chamber container. For the second subject of the invention applies mutatis mutandis what has been said for the first subject of the invention.
Ein dritter Gegenstand der vorliegenden Erfindung ist daher die Verwendung, insbesondere eines kosmetischen Mittels, enthaltend einen Cranberry-Extrakt zur Behandlung von keratinhaltigen Fasern, insbesondere menschlichem Haar.A third aspect of the present invention is therefore the use, in particular of a cosmetic composition containing a cranberry extract for the treatment of keratin-containing fibers, in particular human hair.
In einer bevorzugten Ausführungsform der vorliegenden Erfindung wird das kosmetische Mittel, enthaltend einen Cranberry-Extrakt zur Reparatur und/oder Restrukturierung von geschädigtem Haar verwendet. Besonders bevorzugt wird das erfindungsgemäße Mittel zur Reparatur und/oder Restrukturierung von durch Oxidation oder UV-Licht hervorgerufene Haarschädigung verwendet. Neben dem Repair-Effekt kann das erfindungsgemäße Mittel in einer weiteren bevorzugten Ausführungsform zum Schutz von keratinhaltigen Fasern vor Feuchtigkeitsverlust und/oder vor äußere Einflüsse, wie oxidativer Behandlung oder UV-Strahlung, verwendet werden. Eine weiterhin bevorzugte Ausführungsform der vorliegenden Erfindung umfasst die Verwendung der erfindungsgemäßen Mittel zur Verbesserung des Glanzes keratinhaltiger Fasern, insbesondere menschlicher Haare, zur Verbesserung der Kämmbarkeit keratinhaltiger Fasern, insbesondere menschlicher Haare, zur Verbesserung des Griffs keratinhaltiger Fasern, insbesondere menschlicher Haare, und zur Verbesserung der Formgebung keratinhaltiger Fasern, insbesondere menschlicher Haare. In einer besonders bevorzugten Ausführungsform wird das erfindungsgemäße Mittel auf gefärbten oder getönten keratinischen Fasern, insbesondere menschlicher Haare, verwendet zumIn a preferred embodiment of the present invention, the cosmetic agent containing a cranberry extract is used for the repair and / or restructuring of damaged hair. The agent according to the invention is particularly preferably used for the repair and / or restructuring of hair damage caused by oxidation or UV light. In addition to the repair effect, the agent according to the invention can be used in a further preferred embodiment for protecting keratin-containing fibers from moisture loss and / or from external influences, such as oxidative treatment or UV radiation. A further preferred embodiment of the present invention comprises the use of the agents according to the invention for improving the shine of keratin-containing fibers, in particular human hair, for improving the combability of keratin-containing fibers, in particular human hair, for improving the feel of keratin-containing fibers, in particular human hair, and for improving the Shaping keratin fibers, especially human hair. In a particularly preferred embodiment, the agent according to the invention is used on dyed or tinted keratinic fibers, in particular human hair, for
Schutz der Haarfarbe vor Auswaschen und/oder Verblassen und zur Verbesserung derHair color protection against washout and / or fading and improvement of hair color
Farbintensität.Color intensity.
Für den dritten Erfindungsgegenstand gilt mutatis mutandis das für den ersten und zweitenFor the third subject of the invention mutatis mutandis applies to the first and second
Erfindungsgegenstand Gesagte.Subject of the invention.
Die folgenden Beispiele sollen den Gegenstand der vorliegenden Erfindung erläutern ohne ihn jedoch zu beschränken. The following examples are intended to illustrate the subject matter of the present invention without, however, limiting it.
Beispiel rezeptu ren A HaarspülungExample Rezeptu A hair conditioner
Figure imgf000018_0001
Figure imgf000018_0001
1 Stenol® 16/18 C16.18-Fettalkohol (INCI-Bezeichnung: Cetearyl Alcohol; 1 Stenol® 16/18 C 16 . 18 fatty alcohol (INCI name: Cetearyl Alcohol;
Fa.Cognis)Fa.Cognis)
2Genamin®KDMP C2o-22-Alkyl-trimethylammoniunnchlorid (INCI: Behentrimonium 2 Genamin® KDMP C 2 O- 22- alkyl-trimethylammonium chloride (INCI: Behentrimium
Chloride; Fa. Clariant)Chloride; Fa. Clariant)
3 Rheocare Ultragel® 300 2-(Trimethylamnnnnonio)ethyl methacrylat chlorid homopolymer 3 Rheocare Ultragel® 300 2- (Trimethylamnnnnio) ethyl methacrylate chloride homopolymer
(INCI: Polyquaternium-37; Fa. Cognis)(INCI: Polyquaternium-37, Cognis)
44 Fruitliquid Cranberry B (INCI: Glycerin Aqua, Vaccinium Macrocarpon Extract; Fa.44 Fruitliquid Cranberry B (INCI: Glycerin Aqua, Vaccinium Macrocarpon Extract;
Crodarom)Crodarom)
B HaarkurB hair cure
Figure imgf000018_0002
Figure imgf000018_0002

Claims

P a t e n t a n s p r ü c h e Patent claims
1. Kosmetische Zusammensetzung zur Behandlung keratinischer Fasern, insbesondere menschlicher Haare, dadurch gekennzeichnet, dass sie in einem kosmetischen Träger einen Extrakt aus Früchten von Vaccinium Macrocarpon (Cranberry-Extrakt) enthält.1. A cosmetic composition for the treatment of keratinic fibers, in particular human hair, characterized in that it contains in a cosmetic carrier an extract of fruits of Vaccinium Macrocarpon (cranberry extract).
2. Kosmetische Zusammensetzung nach Ansprüche 1 , dadurch gekennzeichnet, dass mindestens ein weiterer Wirkstoff, ausgewählt aus der Gruppe, die gebildet wird aus Pantolacton, Carnitin Tartrat, Coenzym Q-10, Ectoin, Pantothensäure, Taurin und deren Derivaten, enthalten ist.2. Cosmetic composition according to claims 1, characterized in that at least one further active ingredient selected from the group consisting of pantolactone, carnitine tartrate, coenzyme Q-10, ectoine, pantothenic acid, taurine and their derivatives, is included.
3. Kosmetische Zusammensetzung nach einem der Ansprüche 1 und 2, dadurch gekennzeichnet, dass als weiterer Wirkstoff Pantolacton enthalten ist.3. Cosmetic composition according to one of claims 1 and 2, characterized in that as further active ingredient pantolactone is included.
4. Kosmetische Zusammensetzungen nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, dass die Mittel den Cranberry-Extrakt in einem Gehalt von 0,0001 bis 3,0 Gew.-%, besonders bevorzugt von 0,01 bis 1 ,0 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung, enthalten.4. Cosmetic compositions according to one of claims 1 to 3, characterized in that the means the cranberry extract in a content of 0.0001 to 3.0 wt .-%, particularly preferably from 0.01 to 1, 0 wt. %, in each case based on the total weight of the composition.
5. Kosmetische Zusammensetzungen nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass zusätzlich mindestens ein Konditioniermittel, ausgewählt aus kationischen Polymeren, kationischen Tensiden und/oder Silikonen, enthalten ist.5. Cosmetic compositions according to any one of claims 1 to 4, characterized in that in addition at least one conditioning agent selected from cationic polymers, cationic surfactants and / or silicones, is included.
6. Kosmetische Zusammensetzungen nach Anspruch 5, dadurch gekennzeichnet, dass das konditionierende Silikon eine Viskosität von 40.000 bis 80.000 mPa s besitzt und ausgewählt ist aus Dimethiconen, Amodimethiconen oder Dimethiconolen.6. Cosmetic compositions according to claim 5, characterized in that the conditioning silicone has a viscosity of 40,000 to 80,000 mPa s and is selected from dimethicones, amodimethicones or dimethiconols.
7. Kosmetische Zusammensetzungen nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, dass sie zusätzlich mindestens einen direktziehenden Farbstoff enthalten.7. Cosmetic compositions according to any one of claims 1 to 6, characterized in that they additionally contain at least one substantive dye.
8. Kosmetische Zusammensetzungen nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass die die Zubereitungen mindestens ein Oxidationsfarbstoffvor- produkt vom Typ der Entwicklerkomponenten enthalten.8. Cosmetic compositions according to one of claims 1 to 7, characterized in that the preparations contain at least one oxidation dye Vor- product of the type of developer components.
9. Verfahren zur Behandlung keratinischer Fasern dadurch gekennzeichnet, dass eine kosmetische Zusammensetzung gemäß einem der Ansprüche 1 bis 8 auf die keratinischen Fasern aufgetragen wird und nach einer Einwirkzeit von wenigen Sekunden bis hin zu 45 Minuten wieder ausgespült wird.9. A method for the treatment of keratinic fibers, characterized in that a cosmetic composition according to any one of claims 1 to 8 is applied to the keratinic fibers and rinsed again after a contact time of a few seconds to 45 minutes.
10. Verwendung eines Mittels gemäß einem der Ansprüche 1 bis 8 zur Behandlung keratinischer Fasern. 10. Use of an agent according to any one of claims 1 to 8 for the treatment of keratinous fibers.
PCT/EP2009/050923 2008-02-29 2009-01-28 Hair treatment means with cranberry extract WO2009106399A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008012068.5 2008-02-29
DE102008012068A DE102008012068A1 (en) 2008-02-29 2008-02-29 Hair treatment with cranberry extract

Publications (1)

Publication Number Publication Date
WO2009106399A1 true WO2009106399A1 (en) 2009-09-03

Family

ID=40568324

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/050923 WO2009106399A1 (en) 2008-02-29 2009-01-28 Hair treatment means with cranberry extract

Country Status (2)

Country Link
DE (1) DE102008012068A1 (en)
WO (1) WO2009106399A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012159918A1 (en) * 2011-05-25 2012-11-29 Unilever Plc Hair colouring product comprising metal ions and a component from vaccinium berries
US8833918B2 (en) 2011-02-17 2014-09-16 Fujifilm Corporation Ink composition, ink set, and image forming method
WO2016096267A1 (en) * 2014-12-17 2016-06-23 Henkel Ag & Co. Kgaa Hair treatment agent containing at least one acid protein and at least one salt
SE2250019A1 (en) * 2021-01-14 2022-07-15 Cutrin Oy Hair conditioner composition
WO2022246529A3 (en) * 2021-05-26 2022-12-29 Sensient Cosmetic Technologies Compositions and methods to protect against oxidative hair dyes allergens

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3122835A1 (en) * 2021-05-17 2022-11-18 Societe Industrielle Limousine D'application Biologique Vaccinium macrocarpon extract and its anti-aging cosmetic effects

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980869A (en) * 1997-04-28 1999-11-09 The Procter & Gamble Company Dual phase oral compositions comprising a plant extract from the Ericaceae family
EP1661576A1 (en) * 2004-11-15 2006-05-31 Pharmatoka SAS New dermatological and/or cosmetic use of a plant extract
US20060147397A1 (en) * 2002-11-07 2006-07-06 Kose Corporation Composition for preparation for external use on skin and method of using the same
US20070059343A1 (en) * 2005-05-03 2007-03-15 Chinsammy Sridat S Pet life

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
US4265878A (en) 1979-06-07 1981-05-05 Dow Corning Corporation Antiperspirant stick compositions
JPS5699407A (en) 1980-01-09 1981-08-10 Kao Corp Hair rinse composition
US4393886A (en) 1980-09-05 1983-07-19 Ciba-Geigy Corporation Mixtures of quaternary, polymeric, high molecular weight ammonium salts, which are based on acrylic compounds, and surfactants, their preparation, and their use in cosmetics
JPS5813700A (en) 1981-07-17 1983-01-26 花王株式会社 Detergent composition
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
EP0217274A3 (en) 1985-09-30 1988-06-29 Kao Corporation Hair cosmetic composition
DE3708451A1 (en) 1987-03-16 1988-10-06 Henkel Kgaa ZWITTERIONIC POLYMERS AND THEIR USE IN HAIR TREATMENT AGENTS
DE3929973A1 (en) 1989-09-08 1991-03-14 Henkel Kgaa HAIR CARE
DE4413686C2 (en) 1994-04-20 1996-10-24 Henkel Kgaa Cationic sugar surfactants, process for their preparation and their use
GB9708182D0 (en) 1997-04-23 1997-06-11 Dow Corning Sa A method of making silicone in water emulsions
DE19738866A1 (en) 1997-09-05 1999-03-11 Henkel Kgaa Low-foaming surfactant mixtures with hydroxy mixed ethers
DE19756454C1 (en) 1997-12-18 1999-06-17 Henkel Kgaa Surface-active compositions, especially cosmetics, containing glycerol carbonate as emulsifier
US5998537A (en) 1998-09-21 1999-12-07 Dow Corning Corporation Emulsions containing ultrahigh viscosity silicone polymers
FR2785183B1 (en) 1998-11-04 2002-04-05 Oreal TINCTORIAL COMPOSITION CONTAINING CATIONIC DIRECT DYE AND PYRAZOLO- [1,5-a] - PYRIMIDINE AS OXIDATION BASE, AND DYEING METHODS
DE29908573U1 (en) 1999-05-14 1999-08-05 Wella Ag Hair dye
WO2002010257A1 (en) 2000-07-27 2002-02-07 Ge Bayer Silicones Gmbh & Co. Kg Polyammonium-polysiloxane compounds, methods for the production and use thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980869A (en) * 1997-04-28 1999-11-09 The Procter & Gamble Company Dual phase oral compositions comprising a plant extract from the Ericaceae family
US20060147397A1 (en) * 2002-11-07 2006-07-06 Kose Corporation Composition for preparation for external use on skin and method of using the same
EP1661576A1 (en) * 2004-11-15 2006-05-31 Pharmatoka SAS New dermatological and/or cosmetic use of a plant extract
US20070059343A1 (en) * 2005-05-03 2007-03-15 Chinsammy Sridat S Pet life

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8833918B2 (en) 2011-02-17 2014-09-16 Fujifilm Corporation Ink composition, ink set, and image forming method
WO2012159918A1 (en) * 2011-05-25 2012-11-29 Unilever Plc Hair colouring product comprising metal ions and a component from vaccinium berries
WO2016096267A1 (en) * 2014-12-17 2016-06-23 Henkel Ag & Co. Kgaa Hair treatment agent containing at least one acid protein and at least one salt
US10780038B2 (en) 2014-12-17 2020-09-22 Henkel Ag & Co. Kgaa Hair treatment agent containing at least one acid protein and at least one salt
SE2250019A1 (en) * 2021-01-14 2022-07-15 Cutrin Oy Hair conditioner composition
WO2022246529A3 (en) * 2021-05-26 2022-12-29 Sensient Cosmetic Technologies Compositions and methods to protect against oxidative hair dyes allergens

Also Published As

Publication number Publication date
DE102008012068A1 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
EP2262473A2 (en) Hair treatment means with cloudberry extract
DE102016200688A1 (en) Keratin fiber-sparing agents and methods for oxidative hair coloring
EP2897576B1 (en) Composition for treating keratinous fibres, comprising specific aminosilicones, acids and direct dyes
EP1690524A2 (en) Cationic cellulose derivatives in cosmetics
EP3079653A1 (en) Method for straightening, conditioning and colouring hair, especially hair with substantial curl
WO2009106399A1 (en) Hair treatment means with cranberry extract
DE102016209468A1 (en) Hair-sparing agents and methods of oxidative hair dyeing or bleaching with selected dicarboxylic acids
EP2608848B1 (en) Bleaching with reductive pre-treatment
EP1179339A2 (en) Cosmetic agent containing extracts of malvaceae seeds
WO2015086230A1 (en) Hair straightening through glyoxylic acid
DE102020209041A1 (en) "Means for the treatment of keratin fibers with complexing agent and amino acid and/or protein hydrolyzate"
EP1404286A1 (en) Hair treatment agent comprising betains
WO2016139125A1 (en) Cosmetic agent with bioactive substance and a dipeptide
EP3644946A1 (en) Product for lightening hair, containing special oxo-carboxylic acids
EP0648104B1 (en) Hair-treatment agents
WO2016091785A1 (en) Cosmetic compositions with a proteolipid and methionylmethionine
WO2009109426A1 (en) Hair treatment agent with goji extract
WO2009109425A1 (en) Hair treatment agent comprising acai-extract
DE102012215046A1 (en) Use of (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene for producing cosmetic composition e.g. for stimulating hair keratins synthesis and cell viability
WO2015086269A1 (en) Method and kit for straightening and colouring hair with enhanced grey coverage and enhanced wash resistance
EP2810697A1 (en) Hair-growth agent containing Leontopodium extract
DE102015216687A1 (en) "High-performance hair treatment products with a proteolipid and a magnesium salt"
WO2008031685A1 (en) Root extract of harpagophytum for stimulating hair growth
EP0742709B1 (en) Complex of active ingredients for hair conditioners
DE102015216690A1 (en) Powerful hair treatment agent with an oligopeptide and a magnesium salt

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09715786

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09715786

Country of ref document: EP

Kind code of ref document: A1